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ABSTRACT 
ROLE OF KVβ2 SUBUNITS IN REGULATION OF 
RESISTANCE ARTERIAL TONE 
Sean M. Raph 
November 18th, 2020 
Voltage-gated potassium (Kv) channels control vascular resistance and facilitate 
the augmentation of myocardial blood flow in response to increases in cardiac workload 
(i.e., metabolic hyperemia). Native sarcolemmal Kv1 channels in arterial myocytes 
associate with a heteromeric auxiliary complex consisting of intracellular Kvβ1 and Kvβ2 
proteins. The Kvβ proteins differentially regulate the function of heterologously expressed 
Kv channels, as well as native Kv1 channels in excitable cells of the cardiovascular and 
nervous systems. The physiological importance of vascular Kvβ proteins in mediating 
vasodilation remains unknown. In this study, I tested the hypothesis that Kvβ proteins 
functionally regulate vascular tone in response to an altered pyridine nucleotide redox 
state. I evaluated ex vivo vasoreactivity of small diameter mesenteric arteries isolated from 
wild type (WT), mutant mice in which either Kv channel subfamily a member regulatory 
beta subunits 1 or 2 (Kcnab1 or Kcnab2, respectively) was deleted (i.e., Kvβ1.1-/- and 
Kvβ2-/-, respectively), transgenic mice in which kcnab1.1 overexpression was induced by 
addition of doxycycline to the water (SM22α-rtTA: TRE β1) and point mutant mice in which 
the Kvβ2 subunit was catalytically inactive (Kvβ2Y90F). Loss of Kvβ1.1 or Kvβ2 did not 
significantly impact vasoconstriction in response to elevated extracellular K+ (60 mM), 
vi 
U46619 (thromboxane A2 analogue), or increases in intravascular pressure. Whereas 
vasodilation in response to application of adenosine (10-6 – 10-4 M) was similar between 
Kvβ-null and WT groups, vasodilation in response to external L-lactate (5-20 mM), which 
modifies cellular pyridine nucleotide redox state , was sensitive to inhibition by the Kv1-
selective inhibitor psora-4 (500 nM) and was abolished in arteries from Kvβ2-/- mice but 
not in arteries from Kvβ1-/- mice. Interestingly, arteries from mice in which overexpression 
of the Kvβ1 subunit (SM22α-rtTA: TRE β1) and point-mutated inactivation of Kvβ2 
(Kvβ2Y90F) enzymatic function, similarly abolished vasodilation in response to external L-
lactate (5-20 mM). Our results indicate that vascular tone is differentially regulated by Kv1-
associated Kvβ proteins, whereby Kvβ2 promotes and Kvβ1.1 opposes lactate induced 
vasodilation. Additionally, our data signify the importance of the Kvβ-subunit complex 
composition and enzymatic function in promoting vasodilation in response to an altered 
pyridine nucleotide redox state. 
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Adequate blood flow requires an adaptive, dynamic system, capable of matching 
oxygen and nutrient supply to organ metabolic demand.1  Small resistance arteries (~100-
300 µm) 2 contractile state is modified to alter blood flow and prevent tissue ischemia 
during increased metabolic activity. Disruptions in blood flow can result in ischemic injury 
and organ failure that increases the risk of morbidity and death.3,4 The intricate 
mechanisms underlying metabolic regulation of blood flow are poorly understood. 
The concentration of vascular smooth muscle global cytosolic free Ca2+ ([Ca2+]i 
regulates arterial tone. In the vascular smooth muscle cell, [Ca2+]i is predominantly 
determined by sarcolemmal membrane potential and Ca2+ influx via L-type voltage-
dependent Ca2+ channels (VDCC).5 This literature review will discuss the major known 
mechanisms of arterial tone regulation. Part one of this review will discuss vascular 
smooth muscle mediated arterial tone regulation, focusing on mechanisms of ion channel 
mediated vascular tone regulation. Part two will discuss the biochemical and physiological 
properties of K+ channel associated AKR6A (KVβ) proteins. This literature review will 
provide the base evidence for investigating the role of KVβ proteins in regulating arterial 
tone.a  
a Parts of the following thesis have been previously published with Sean Raph listed as co-first author or first author, respectively; 6
Ohanyan, V. et al. Myocardial Blood Flow Control by Oxygen Sensing Vascular Kvbeta Proteins. Circ Res, 
doi:10.1161/CIRCRESAHA.120.317715 (2021); 7 Raph, S. M., Bhatnagar, A. & Nystoriak, M. A. Biochemical and physiological 
properties of K(+) channel-associated AKR6A (Kvbeta) proteins. Chem Biol Interact 305, 21-27, doi:10.1016/j.cbi.2019.03.023 (2019). 
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b. Part 1: Resistance artery physiology 
 
Resistance Artery Myogenic Tone Regulation 
 
 Resistance arteries are those arteries with a diameter in the range of ~100-300 
µm.8 These small resistance arteries exhibit a large dynamic range of arterial distention 
and significantly influence blood pressure and flow. Adequate supply of blood flow to 
organs requires arteries that can adequately dilate in response to the metabolic demand 
of the supplied organs and tissues. To allow for adequate O2 and nutrient supply, the 
resistance arteries must allow for greater blood flow. This is achieved in one of two ways; 
1) the heart can pump harder, forcing a greater volume of blood through the same 
diameter ‘tube’ in turn increasing the pressure in the circulatory system, however this will 
further exacerbate the O2 deficit of the heart and therefore is insufficient; or 2) the artery 
can dilate, increasing the diameter of the vessel through which a greater of volume of 
blood can travel. In those events where the heart does pump more blood but small 
resistance arterial dilation is impaired, the tissue becomes starved of oxygen and 
nutrients.9 To match organ blood flow demands, the vascular smooth muscle mediate 
vasoconstriction through a response known as myogenic tone. This is achieved through 
tight regulation of intracellular [Ca2+]i. For example, influx of Ca2+ induces vasoconstriction 
(decreased diameter), while inhibition of Ca2+ influx induces vasodilation (increased 
diameter).10 Calcium enters the vascular smooth muscle cells via L-type voltage-
dependent Ca2+ channels (VDCC), which will be discussed in greater detail later.   
 
Control of blood flow 
 The movement of blood through the circulatory system is dependent on regions of 
variable pressure. Blood moves from regions of high pressure (i.e., aorta) to regions of 
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low pressure (i.e., capillaries). The increase in blood flow parallels this increase in 
pressure (ΔP); however, resistance opposes blood flow. Blood flow is proportional to ΔP 
and inversely proportional to vascular resistance (R) such that: Flow≈ ΔP/R. Furthermore, 
resistance is a function of length (L) and radius (r) of the vessel and viscosity (η) of the 
fluid moving through the vessel and are best expressed by Poiseuille’s Law: R = 8Lη/πr4. 
Because the circulatory system and blood viscosity are generally constant, the equation 
can be refined to the following: R ≈ 1/r4. Therefore, this equation declares that vascular 
resistance is inversely proportional to the vessel radius to the fourth power. For example, 
a change of arterial diameter from 100 µm to 80 µm will result in ~59% reduction in blood 
flow. For example during hyperemia, a regulatory process by which blood flow is modified 
to match changes in metabolic and oxygen demand and prevent ischemia, significant 
changes in arterial diameter are necessary to prevent end organ damage.11 There are 
several situational hyperemia responses; 1) reactive, the response to diminished tissue 
oxygen and increased metabolic waste (ischemia), 2) active, a response to increased 
exertion (i.e., exercise), and 3) infectious or traumatic, as during infection of a cut or 
edema.11 To match these increased demands of the tissues (i.e., brain, skeletal muscle, 
heart) small resistance arteries must dilate. The KV channels play an important role in 
regulating vascular tone during hyperemia.12  This reaffirms that arterial diameter is a 
significant driving force of vascular resistance and even small changes can have 
significant effects on blood flow and end organ perfusion. 
 
Autoregulation and Ca2+ dependence of vascular tone 
 Maintaining constant blood flow during changes in blood pressure requires 
resistance vasculature to constrict in response to increased intravascular pressure and 
dilate in response to reduced pressure. This phenomenon of arterial constriction in 
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response to increased intravascular pressure, or “myogenic tone” was first described by 
Bayliss in the early 1900’s.13 These constrictions resulting from increases in intravascular 
pressure were later identified to be an intrinsic characteristic of arterial wall smooth muscle 
cells independent of other influences (e.g., endothelial).14-16 Additionally, increasing 
intravascular pressure to within the physiological range (60-100 mmHg) results in 
membrane depolarization of vascular smooth muscle cells and activation of voltage 
dependent Ca2+ channels (VDCC), which results in an increase in [Ca2+]i, vascular smooth 
muscle contraction, and vessel constriction.17-19 The effects of pressure and other 
endogenous mediators of arterial tone are significant for regulating a partially constricted 
state in order to match blood flow to metabolic demand in small diameter arteries.20,21 
These various factors (e.g., pressure) contribute to the autoregulation of vascular tone. 
 
Regulation of smooth muscle membrane potential 
 The activity of VDCCs and smooth muscle [Ca2+]i is dependent on the membrane 
potential. The change in membrane potential of vascular smooth muscle cells and [Ca2+]i 
mediated constriction is tightly regulated and is modified by efflux of potassium ions (K+). 
The intracellular and extracellular K+ concentrations, determined by the high permeability 
of the cell membrane and chemical gradient for K+ ions, drive the resting membrane 
potential. This is due to the differing intracellular (~140 mM) and extracellular (~4-6 mM) 
K+ concentrations. However, when the cell membrane becomes depolarized, voltage 
gated potassium channels open to drive hyperpolarization and return to the EK Nernst 
potential. This efflux of K+ diminishes positive charge increasing the electrical driving force 
inward toward the cytoplasm. A major family of K+-selective channels regulates vascular 
smooth muscle cell membrane potential. This section will first describe how regulation of 
ion flow affects membrane potential and then will describe the properties of K+ channels 
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that are expressed in small resistance arteries: voltage dependent (KV), large conductance 
Ca2+ activated (BK), ATP-sensitive (KATP), and inwardly rectifying (KIR) K+ channels. 
 
Membrane polarization of excitable cells: The polarization state of excitable cells (e.g. 
neurons) depends on the flow of positively and negatively charged ions, predominantly 
this includes K+, Na+, and Cl-.22 The movement of ions across the membrane is determined 
by their respective electrical and chemical gradients. When the electrical forces driving 
ions into or out of the cell matches the chemical forces driving ions into or out of the cell, 
this determines the membrane potential at which there is no net flow of that ion in either 
direction across the membrane, this is known as the equilibrium potential. The equilibrium 
potential for each respective ion (X) can be calculated using the Nernst Equation, 
EX = (RT/zF)*ln([X]O/[X]i) 
where R is the gas constant, T is temperature, z is the charge of the ion, F is the Faraday 
constant, and [X]O, [X]i are the external and internal ion concentrations (mM). Further 
simplified, this can be written as  
EX = 58 mV/1*log([X]O/[X]i) 
Using this we can calculate the equilibrium potential (EK) for K+, to be approximately -90 
mV, when [K+]O = ~4.7 and [K+]I = 150.19 These equations are used to determine the 
contributions of the different ions to the resting membrane potential. By using the Goldman 
equation,23 Hodgkin and Huxley analyzed the respective contributions of ions to 
membrane potential of the squid giant axon.24-26 They observed that K+ had the greatest 
contribution to the resting membrane potential. Furthermore, the resting membrane 
potential for many excitable cells is driven by EK (~90 mV) meaning the membrane is most 
permeable to potassium. Since Hodgkin, Huxley, and Katz established that membrane 
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excitability is largely maintained by K+ channels27-31, numerous investigations have found 
numerous K+ specific channels32, which regulate a multitude of different physiological 
processes.33-35    
 
Inwardly rectifying channels: Inwardly rectifying (KIR) channels have evolved voltage 
independent mechanisms of activation such as gating by G-proteins, pH, and ATP. Unlike 
other K+ channels (e.g. KV) the KIR are comprised of two membrane spanning helices.36 
Additionally, these channels more readily pass K+ ions inward than outward when 
membrane potential is negative to EK; however, arterial myocyte membrane potential is 
positive to EK and currents through these KIR channels is low. Hyperpolarization occurs 
when external K+ is elevated and K+ efflux through KIR occurs.37 Additionally, KIR may by 
activated by cellular release of K+ during hypoxia and ischemia.38 As a result, K+-induced 
dilation during reduced oxygen and nutrient delivery in metabolically active cells is a result 
of KIR and may be an important mechanism to increase blood flow and prevent ischemia. 
 
ATP inactivates the ATP-sensitive potassium channels: The inward rectifying ATP-
sensitive potassium channels (KATP) are inhibited when the intracellular ATP:ADP ratio 
increases. The KATP channels are comprised of pore-forming subunits and sulfonylurea 
receptor subunits. This gives rise to the sensitivity of KATP channels to sulfonylurea 
inhibitors like glibenclamide.39 Activation of KATP channels mediates vasodilation via the 
sulfonylurea receptor subunits and adenosine A2 receptor.40 ATP hydrolysis produces 
adenosine, this binds to adenosine type 2A receptors, a G-coupled protein which 
stimulates adenylate cyclase and increases cyclic-AMP.41 Through this mechanism, KATP 
channels are activated, hyperpolarizing the cell membrane, inhibiting VDCC mediated 
Ca2+ influx and inducing vasodilation.41 As adenosine is a product of increased metabolic 
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activity,  KATP channels are included in the growing list of modifiers of blood flow; however, 
recent reviews provide collected evidence that KATP channels may not be key mediators 
of coronary vasodilation in response to exercise.2,42-45   
 
Large conductance Ca2+ activated potassium channels: The large conductance Ca2+ 
activated potassium channels (BK) are comprised of four α-subunits, which form an ion 
conducting pore and associated β subunits. Genetic ablation (i.e. BK-/-) and or 
pharmacological inhibition of BK channels induces constriction and greater myogenic 
tone, thus reducing blood flow in BK-/- mice as compared with wildtype.46-48 The BK 
channels mediate K+ efflux in response to local release of sarcoplasmic reticulum Ca2+ by 
ryanodine receptor mediated calcium sparks.49-52 The BK-mediated efflux of K+ drives 
membrane hyperpolarization, which inhibits VDCC facilitated Ca2+ influx and induces 
vasodilation.49 The release of sarcoplasmic intracellular Ca2+ mediated by ryanodine 
receptors, which in turn activate BK channels signify yet another important mechanism 
that regulates blood flow.       
 
Voltage dependent K+ channels: The voltage dependent potassium (KV) channels are 
comprised of ~35 genes that can be further categorized into 12 families expressed in 
excitable cells. There are several KV channels expressed in small resistance arteries 
including members of the KV1, KV2 and KV7 families.53 The KV channels are comprised of 
a heteromeric pore formed by KVα-subunits, which consist of six transmembrane helices 
(S1-S6) with S5-S6 forming the ion conducting pore and S4 containing the voltage sensor 
region.53 Additionally, the KVα complex associates with intracellular β-subunit complex, 
which binds the α-subunit at the intracellular T1 region. The β-subunits bind endogenous 
cofactors and substrates, which modify KVα channel activity. KV channels play a significant 
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role in mediating vasodilatory control in response to altered metabolic demand.54 There is 
significant  evidence that functional KV channels are crucial in regulating arterial tone.19,55 
Additionally, KV channels are crucial to modifying coronary blood flow in mice56, and play 
a role in adaptive and innate immune cell development57, neuronal diseases such as 
epilepsy58, and sleep59, and hyperpolarization of excitable cells.60  
 
Endothelial influences 
 Since the discovery of the endothelium in the late 1800’s, it has been perceived as 
an entity separate and inert from other segments of the vasculature. However, the 
mechanisms of endothelial regulation of vascular function have been intently investigated. 
This section will provide an overview of several major endothelial originating factors that 
influence vasodilation, including nitric oxide (NO), endothelium derived relaxing factor 
(EDRF), and endothelin-1 (ET-1). 
 
Nitric oxide: Nitric oxide (NO) plays an important role in regulating vascular tone.61,62 
Acetylcholine, first isolated and synthesized in the 19th century by Adolf von Baeyer and 
later by Dudley and others63,64, stimulates vasodilation via increased nitric oxide synthase 
(NOS).65 The effect of acetylcholine induced vasorelaxation was first recognized by Mott 
and Halliburton in the early 1900’s, when small concentrations decreased blood pressure 
in laboratory animals.66 Decades later,  a functional role for the endothelium was observed 
when Furchgott and Zawadski directly noted acetylcholine induced smooth muscle 
relaxation.67 It was not until 1987 when, separately, Ignarro68,69 and Palmer70, 
independently identified nitric oxide (NO) as the mediating factor. After these influential 
discoveries, several ligands were identified (e.g., bradykinin, acetylcholine) which bind to 
endothelial receptors and mediate a cascade that initiates activation of enzymes in the 
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nitric oxide synthase (NOS) pathway.  Both agonists and sheer stress induce increased 
production of endothelial NO.71,72 Due to either endothelial agonist or sheer stress 
stimulation of the NOS enzymatic machinery converts L-arginine to L-citrulline and NO is 
produced as a byproduct.73 NO then diffuses from endothelial cells to vascular smooth 
muscle cells where NO activates soluble guanylate cyclase (sGC), which increases cyclic 
guanosine monophosphate (cGMP) production.74 Elevated cGMP activates PKG, which 
inhibits IP3R mediated sarcoplasmic Ca2+ release, this decreases intracellular Ca2+, and 
results in vasorelaxation.74,75 However, there are other mechanisms of vasodilation 
discussed in great detail in these reviews.76-78 Additionally, NO plays a role in numerous 
other mechanisms such as, angiogenesis79, apoptosis73, neurotransmission, inflammation 
response, and thrombosis.80 Although NO has been proposed as a key mediator of 
coronary vasodilation several studies have shown that blockade of NO does not 
significantly influence coronary dilation in response to increased cardiac work (i.e. 
exercise).72,81 It has also been shown that blockade of NOS has a negligible effect on 
metabolic coronary vasodilation during exercise.8,81-83 It has been proposed that 
endothelial mediated control acts to preserve a reserve dilatory capacity in order to 
prevent excessive shear stress.8,84  
 
Endothelial derived relaxing factors: There have been numerous endothelial derived 
relaxing factors (EDRF) identified, including ADP, CGRP, thrombin, P450 metabolites of 
arachidonic acid, H2S, and H2O2.85-87 EDRF molecules activate soluble guanylate cyclase, 
this increases cyclic-GMP (c-GMP) in the vascular smooth muscle. NO binds to soluble c-
GMP and starts a signaling cascade that drives vasorelaxation (described in further detail 
above in “Nitric oxide”). These EDRF molecules exact local or direct change to vascular 
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tone in response to changes in metabolic demand.88 This is further evidence of a 
multifaceted compensatory mechanism to ensure proper blood flow regulation.89  
 
Endothelin-1: The vasoconstrictor endothelin (ET) is expressed as three isoforms, though 
endothelial cells express only ET-1. The precursor to ET-1, Big ET-1, is converted to ET-
1 by endothelin converting enzyme.90 Receptors for ET-1 have been identified in both 
vascular smooth muscle and endothelial cells and distribution of different receptors is 
dependent on the type of vascular bed. Extracellular Ca2+ enters the cells when ET-1 binds 
ETA or ETB2 receptors; however, the ETB1 receptor is also linked to NO- and PGI2-mediated 
vasodilation.75 ET-1 increases the sensitivity of myosin light chain (MLC) to Ca2+, inducing 
vasoconstriction.91 Additionally, ET-1 induced Ca2+ increase is inhibited by nicardipine, 
and vasoconstriction is inhibited by the inhibitor of the ETA receptor BQ-123, but not the 
ETB agonist IRL 1620.91 The ET-1-induced constriction is impaired by either BQ-123 or 
GDPβS in the presence of increased Ca2+.91 Additionally, there is evidence supporting a 
role for ET-1 in the development of vascular diseases in which blood flow is impaired.92 
Despite being an essential regulator of vascular tone, high levels of ET-1 contribute to 
enhancement of hypoxia induced hypertension via inhibition of KCa channel 
conductance.93 Importantly, ET-1 at low concentrations increases KCa activity, but in 
excess of 5 nM, ET-1 inhibits KCa conductance.93 Importantly, high levels of ET-1 mediated 
vasomotor control can detrimentally contribute to dysregulated blood flow.    
 
 Taken together, these different pathways act as complements to one another in 
regulation of arterial tone and therefore blood flow. It is crucial to remember that no single 
regulator is sufficient to modify blood flow or arterial tone in response to all stimuli. 
Therefore, the vasculature has evolved numerous complementary mechanisms that 
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regulate the vasodilatory response to exogenous and endogenous signals. However, 
understanding the various modifiers of arterial tone (e.g., KV channels) requires a deeper 
understanding. We will describe the link between the role of KV channels and their 
associated auxiliary subunits as crucial regulators of arterial tone in further detail in this 
review and with the entirety of this work. 
 
c. Part 2: Biochemical and physiological properties of K+ channel associated AKR6A 
(KVβ) proteins 
Voltage-gated potassium (KV) channels play an essential role in the regulation of 
membrane excitability and thereby control physiological processes such as cardiac 
excitability, neural communication, muscle contraction, and hormone secretion. Members 
of the Kv1 and Kv4 families associate with auxiliary intracellular Kvβ subunits, which 
belong to the aldo-keto reductase superfamily. Electrophysiological studies have shown 
that these proteins regulate the gating properties of Kv channels. Although the three gene 
products encoding Kvβ proteins are functional enzymes in that they catalyze the 
nicotinamide adenine dinucleotide phosphate (NAD[P]H)-dependent reduction of a wide 
range of aldehyde and ketone substrates, the physiological role for these proteins and 
how each subtype may perform unique roles in coupling membrane excitability with 
cellular metabolic processes remains unclear. Here, we discuss current knowledge of the 
enzymatic properties of Kvβ proteins from biochemical studies with their described and 
purported physiological and pathophysiological influences. 
 The aldo-keto reductases (AKRs) comprise a group of oxidoreductase enzymes 
that catalyze the reduction of endogenous and xenobiotic carbonyl compounds. These 
enzymes are ubiquitous among eukaryotic and prokaryotic organisms and share 
significant structural identity in that they all possess a C-terminal active site region within 
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a triose-phosphate isomerase (TIM) barrel (α8/β8) motif with three loops at the base of the 
barrel that govern substrate binding.94,95 The utility of this structural arrangement among 
the AKRs allows for flexibility in binding and metabolizing a wide range of chemical 
substrates that includes aliphatic and aromatic aldehydes and ketones, monosaccharides, 
steroids, and polycyclic aromatic hydrocarbons.96-98 All AKRs require nicotinamide 
adenine dinucleotides (i.e., NAD(P)H) as a cofactor for hydride transfer 99 and their 
function can thus be modulated by the cellular redox state of electron carriers used in 
many intermediary metabolic reactions.  
 Most human AKRs are soluble monomeric proteins that are found in the cytosolic 
compartment. An exception to this are members of the AKR6 subfamily, which form 
tetrameric complexes that are associated with the pore-domains of voltage-gated 
potassium (Kv) channels (i.e., the Kvβ proteins).100,101 The Kv channels are a large family 
of transmembrane K+-permeable ion channels that, via regulation of membrane potential 
in excitable cell types, control numerous physiological processes, including neuronal 
excitability, hormonal secretion, and muscle contraction.35,102,103 While this assembly 
between a catalytically active AKR and ion channel has stimulated several intriguing 
hypotheses regarding its evolutionary conservation and potential physiological role(s) 104, 
there is limited information about the potential in vivo role for the Kvβ proteins in the 
cardiovascular, endocrine, and nervous systems, and it is unclear how these proteins may 
regulate diverse cellular physiological processes and pathophysiological development. 
While the enzymatic properties and cellular functions of the AKR family have been 
reviewed (readers are referred to 95,105), we will discuss the enzymatic properties of the 
Kvβ proteins, including how these properties may relay metabolic information to the Kv 
channel gating apparatus. Additionally, these subunits may serve as molecular 
transducers that couple metabolism and membrane electrical signaling in excitable cell 
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types. While underscoring key remaining questions that require further investigation, we 
discuss the potential efficacy of small molecules or peptides that selectively modulate Kvβ 
expression or functionality as a novel class of therapeutics that could prevent or reverse 
pathological changes, and therefore may be useful interventions for controlling excitability 
under a variety of different physiological and pathological conditions.   
 
Molecular and structural biology 
In the human genome, there are ~35 genes encoding Kv channel pore proteins 
belonging to 12 subfamilies (i.e., Kv1.x – Kv12.x).106 The basic Kv channel tertiary 
structure consists of a multi-subunit complex of pore-forming proteins with a diverse 
repertoire of associated auxiliary and regulatory proteins. The pore domain is formed by 
the tetrameric assembly of four distinct transmembrane subunits (α) that are arranged 
around a central axis to form a membrane-traversing ion conduction pore that is highly 
selective (~10,000 fold more selective for K+ than for Na+) and efficient for K+ transport 
(~107 K+ ions channel-1 sec-1).107-109 Kvα subunits are 70-100 kDa in mass and consist of 
six membrane-spanning α helices (S1-S6) with S1-S4 forming the voltage-sensor domain 
and the S5-S6 segments of each contributing to the pore lining with selectivity filter. A 
highly conserved series of positively charged arginine residues within the S4 region form 
the voltage sensor of the channel that responds to changes in membrane voltage to 
constrict or dilate the central pore.110 In native channel complexes, members of a particular 
Kv family (e.g., Kv1) are known to interact with other functional members of the same 
family, giving rise to heteromeric alpha pore complexes with variable gating properties, 
which could ultimately increase diversity among functional channels.111,112 This is thought 
to occur through highly conserved regions within the intracellular T1 domain, which also 
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serves as a docking site for intracellular subunits. Association with conserved regions 
among accessory Kv proteins also allows for the formation of heterotetrameric auxiliary 
subunit complexes, which, as described below, may further add to the functional diversity 
of native channels.   
Although the expression and assembly of four Kvα subunits is the minimum 
requirement to form a functional channel, association of the pore-domain with a diverse 
set of accessory subunits, such as Kvβ, KChAP, KChIP, and MinK, imparts multimodal 
regulatory features to Kv channels in vivo.113 Members of the Shaker (Kv1) and Shal (Kv4) 
families are known to associate with Kvβ subunits.114,115 The human genome contains 
three genes that encode Kvβ proteins (KCNAB1, KCNAB2, KCNAB3) and their transcripts 
are alternatively spliced to generate additional variants. Early studies suggesting the 
functional importance of Kvβ proteins discovered that a leg shaking phenotype in 
Drosophila melanogaster (i.e., ‘hyperkinetic’) was the result of a mutation in a homologue 
of the mammalian Kvβ peptides. Subsequent sequence analyses led to the unexpected 
finding that the Kvβ subunits shared significant homology (15-30% amino acid identity) 
with members of the AKR superfamily.104,116 Upon crystallization of Kv1.2-Kvβ2, it was 
found that Kvβ proteins possess a conserved C-terminal β-barrel structural fold with tightly 
bound nicotinamide cofactor and, consistent with findings from sequence alignments, the 
active site had all characteristic features of a catalytically active AKR, including a well-
conserved cofactor binding site and a distinct substrate binding pocket.100,117 Indeed, in 
these earlier reports on the X-ray crystal structure of a Kv channel complex, and more 
recently in a study demonstrating the single-particle cryo-electron microscopic structure 
of Kv1.2-Kvβ2 expressed in lipid nanodiscs 118, electron density could be resolved from 
NADP+ that was bound to the β subunits.  
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The active site structure of the AKR6 family is unique in that the α8/β8 motif has an 
additional helix attached to a long loop between β9 and α7 near the cofactor binding 
pocket.95 The functional significance of this modification that is shared among AKR6 
members is not presently clear. At the quaternary level, the β1 and β2, which are 
perpendicular to the central axis of the barrel, along with the  α2-β5-α3 region, form the 
intersubunit interface region that participates in β tetramerization,  while the α5-α6 region 
interacts with the T1 docking domains of the Kvα proteins.100,101 Thus, via the T1 domain, 
the active site of Kvβ can influence the conformation of the voltage sensing apparatus and 
thereby impact gating properties because of catalytic activity and/or pyridine nucleotide 
cofactor binding. 
 
Enzymology and channel biophysics  
A prerequisite for investigating and understanding the potential physiological or 
pathological roles of the Kvβ proteins is a thorough understanding of their catalytic 
properties and the identification of potentially relevant endogenous or xenobiotic carbonyl 
substrates. The Kvβ proteins bind pyridine nucleotides, with binding affinities in the low 
micromolar range (i.e., 0.1-4 μM). The proteins display a ~10-fold greater affinity for 
NADP(H) compared to NAD(H) cofactors.119 Considering that in most metabolically active 
cells, the NADPH:NADP+ ratio is substantially higher than that of NADH:NAD+, while the 
absolute concentration of NADP(H) is much lower than that of NAD(H) 120,121, the cofactor 
predominantly used by Kvβ proteins in vivo is not clear and likely varies with respect to 
cell type. Kvβ2 catalyzes the reduction of a wide range of aldehydes and ketones, although 
preferential binding and reduction of aldehydes versus ketones, and higher catalytic 
efficiency for aromatic aldehydes was reported for this subunit.122 For example, Kvβ2 
shows higher catalytic activity with aromatic carbonyls such as phenanthrenequinone than 
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with straight chain aldehydes such as acrolein or 4-oxo-nonenal.122 Little or no activity was 
observed with steroids such as cortisone. Significantly, the protein was also found to be 
active with products of lipid peroxidation, such as 1-palmitoyl, 2-oxovaleroyl, phosphatidyl 
choline (POVPC). Given that POVPC and related aldehydes are generated during the 
oxidation of unsaturated fatty acids in the plasma membrane and that Kvβ is tethered 
within close proximity to the membrane, it appears plausible that the catalytic function of 
Kvβ may be to detoxify lipid peroxidation products and thereby protect Kv channels from 
oxidative damage. Alternatively, binding to lipid peroxidation products could be a potential 
regulatory mechanism that could alter Kv kinetics under conditions of oxidative stress 
(e.g., to trigger apoptosis). Although future studies are required to distinguish between 
these possibilities and to identify other endogenous substrates, the catalytic reactivity of 
the protein with aldehydes could represent an important link that would regulate Kv 
channel activity as a function of Kvβ catalysis (regulation of electrical activity by 
metabolism) or Kvβ catalysis by Kv activity (regulation of metabolism by electrical activity). 
In either scenario, the link between metabolism and excitability could represent a 
regulatory mode with profound implications for neural, cardiac, and muscle excitability.   
The catalytic activity of Kvβ2 has been found to be sensitive to both pH and ionic 
strength. Measurements of the enzyme activity at various pH and ionic concentrations 
found that enzyme activity is maximal between pH 7.2-7.4 and relatively insensitive to 
varied phosphate concentrations between 100 mM and 250 mM. Yet, at low phosphate 
concentrations (≤ 50 mM), enzymatic activity is significantly decreased 122-124 and is not 
impacted by the addition of NADH and or NAD+, suggesting that the enzyme functions 
most effectively at a specific ionic strength. As with other AKRs such as aldose reductase 
and aldehyde reductase, the mechanism of Kvβ catalysis is consistent with an ordered bi-
bi rapid equilibrium reaction in which the nucleotide cofactor is the first to bind and the last 
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to dissociate. Consistent with this, the binding affinities for NADPH and NADP+ by Kvβ2 
are significantly different, as NAD(P)H binds with 4-times greater affinity than NADP+. The 
sequence of cofactor and substrate binding was confirmed using variable concentrations 
of 4-NB and NADPH to establish the initial velocity, the starting rate of enzymatic activity. 
When plotting initial velocity against the different NADPH concentrations, a rapid 
equilibrium mechanism was predominant, indicative of NADPH binding prior to 
substrate.122 
The cofactor binding kinetics for Kvβ2, determined by monitoring the reduction in 
fluorescence of the Kvβ2 reporter fluorescence by addition of each respective cofactor, 
provided insight into the phasic behavior and rate limitation of catalysis.123 By measuring 
the dependence of observed kfast and kslow of kinetic traces on NADP(H) concentration, it 
was suggested that the binding of NAD(P)H to Kvβ could be described as a three-step 
process consisting of rapid formation of a loose enzyme-cofactor association, a slow 
conformational change that securely seats the cofactor in the active site of the enzyme, 
and further stabilization of the NADPH cofactor to its binding site.122,123 The binding of 
NADP+, however, follows the two step model of binding affinity, suggesting that the second 
conformational change observed with NADPH binding that prevents nucleotide exchange 
is absent in the binding of oxidized nucleotide.123 Moreover, studies performed using 
mutant Kvβ2 in which the catalytic site tyrosine (Y90) is replaced with phenylalanine 
(Kvβ2Y90F) suggest that high affinity nucleotide binding is not significantly impacted by loss 
of catalytic function.122  
By binding of cofactors to the Kvβ subunits, Kv channel activation and inactivation 
are sensitive to changes in intracellular pyridine nucleotide redox state, which is reflected 
in the ratio of intracellular NAD(P)H/NAD(P)+.124 Modulation of Kv activity by oxidized and 
reduced pyridine nucleotides is determined by the identity of Kvβ subunits present.125,126 
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Unlike Kvβ1 and Kvβ3, the Kvβ2 subunit lacks an inactivating N-terminus tail-like 
structure.127,128 Despite this structural difference, Kvβ2 has a common binding affinity to 
the α subunit T1 domain.100 Consistent with this, the C-terminal domain of the Kvα subunits 
is critical for proper association between the Kvα and β subunits.126,129 The underlying 
region of importance in the Kv1α C-terminal domain lies between Arg-543 and Val-583 of 
Kv1.5, a region with differential affinities for NAD(P)H-bound versus NAD(P)+-bound Kvβ. 
Thus, nucleotide-dependent modification in subunit binding affinity and associated 
conformational changes within the Kvα transmembrane region may represent a potential 
mechanism whereby Kvβ redox sensing could alter channel biophysical properties.  
The mechanism and biochemical role of cofactor binding in Kvβ-mediated catalysis 
are like that observed with other AKRs, such as aldose reductase. As with other AKRs, 
NAD(P)H binding promotes a change in protein conformation that stabilizes the cofactor 
within the catalytic pocket.123 The affinity of this interaction produces a large change in 
free energy that drives catalysis. As little energy is derived from substrate binding to 
achieve the transition state, the protein can bind a range of carbonyl substrates. This mode 
of high affinity binding to pyridine coenzyme seems well-suited for ion channel regulatory 
functions of Kvβ, as it reduces the constraints of aldehyde binding and renders the cofactor 
binding pocket an effective sensor of intracellular pyridine nucleotides. Thus, physiological 
changes in intracellular NAD(P)H:NAD(P)+ could readily impact Kv gating and membrane 
potential regulation. Under conditions of high intracellular NAD(P)H:NAD(P)+ ratio, binding 
of reduced cofactor generally enhances the degree and rate of channel inactivation.124,126 
However, this effect can be effectively ‘turned off’ upon completion of a catalytic cycle 
resulting in substrate reduction and cofactor oxidation. Accordingly, the net effect of AKR 
enzymatic function on Kv channel activity likely reflects dynamic homeostatic balance 
between pyridine nucleotide redox potential as well as the concentrations and molecular 
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identities of local aldehyde and ketone substrates, which collectively reflect cellular and 
subcellular metabolic activity. 
 
Physiological roles                                                                                    
Regulation of membrane excitability by cellular metabolism: Considering that Kv channel 
gating is modulated by 
intracellular pyridine 
nucleotides via the Kvβ 
complex as stated above, 
these proteins have been 
proposed as a link between 
cellular function and 
metabolic activity. However, 
a clear view of how the Kvβ 
proteins operate and modify 
channel gating behavior in 
their native cellular and tissue 
environments has not yet 
emerged. Complicating this 
issue, native Kv channels 
likely consist of heteromeric assemblies of multiple gene products and splice variants, 
which have not yet been functionally characterized. Moreover, the expression levels of 
Kvα and β proteins and how their stoichiometry within a given population of functional 
channels is determined may be cell specific. It is also conceivable that the molecular 
identity of predominant subunits utilized by a cell may be modified because of changing 
metabolic cues. Considering the functional diversity imparted by variable N-termini of the 
Schematic 1 
 
Schematic 1: Balanced redox regulation of whole cell IKv by differential incorporation of 
Kvβ proteins in heteromultimeric channels. (A) Schematic of Kvβ1, Kvβ2, and Kvβ3 amino acids 
showing conserved COOH terminal region (blue) and variable N-termini (green/red). Several splice variants 
which differ in the N-terminal domain have been found for Kvβ1 (1.1-1.3 and Kvβ2 (2.1, 2.2). Ball-and-chain 
inactivation domain is shown in red. Adapted from 68. (B) Differential regulation of Kv channel inactivation 
by Kvβ1/3 (red) and Kvβ2 (green) in the presence of oxidized and reduced pyridine nucleotides. Adapted 
from 101. Kv channels expressed in membranes of excitable cells represent heterogeneous populations of 
structures with varying β subunit compositions. Channels that assemble with Kvβ1/Kvβ3 proteins 
demonstrate enhanced inactivation upon binding to reduced pyridine nucleotides. Conversely, sensitivity 
of channel inactivation to pyridine nucleotide redox is absent in channels that associate with Kvβ2, which 
does not contain the ball-and-chain. (C) Graph showing proposed regulation of Kv channel activation, 
inactivation, and single channel and whole-cell IKv as the ratio of expressed Kvβ2:Kvβ1 or Kvβ3 is increased. 
A reduction in channel inactivation with increased Kvβ2:Kvβ1/3 in native Kv channels could produce an 
increase in single channel Kv activity and elevation in steady-state IK, which may lead to significant 
alteration in membrane excitability and responsiveness to changes in cellular metabolism. Solid lines 
represent predicted observed effects on whole cell Kv activation, inactivation, and IK. Dashed lines show 
plausible graded effects of Kvβ2:Kvβ1/3 ratio on inactivation and IK. 
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Kvβ subtypes, the ratio of Kvβ2:Kvβ1/3 present in the Kv auxiliary complex could have a 
significant impact on inactivation (Schematic 1).  For example, in channels with non-
inactivating Kvα pore subunits (e.g., Kv1.5) and predominantly Kvβ2 subunits, channel 
inactivation may be slower, as C-type inactivation would be the primary mode of 
inactivation.127 Conversely, in channels consisting of variants of Kvβ1 or 3, channel 
inactivation likely occurs within a faster time frame, as these subunits would contribute to 
rapid N-type inactivation. In addition to interaction and regulation of Kvα function by the 
Kvβ proteins, interaction between multiple types of Kvβ can influence the net function of 
the Kvβ complex on channel gating. For example, incorporation of Kvβ2 can lead to 
significant inhibition of N-type inactivation imposed by Kvβ1 subunits within the same 
channel complex.130 Nonetheless, the extent to which these subunits impact channel 
activation and inactivation would also be dependent upon pyridine nucleotide redox ratios 
in the submembrane compartment, as discussed above. Thus, it is plausible that the cell 
could dynamically fine-tune the regulatory properties of membrane potential to changing 
metabolic conditions by altering the ratio of Kvβ subunits within the population of functional 
membrane-inserted channels. In the remainder of this section, I will provide a brief 
overview of the importance of Kv channels to the cardiovascular, nervous, endocrine, and 
immune systems, and how the functional expression of Kvβ may influence physiological 
processes of excitable cells types within each. 
 
Cardiovascular system: In the mammalian heart, multiple types of Kv channels mediate 
outward K+ currents with variable activation and inactivation properties that collectively 
shape the cardiac action potential.131,132 Attesting to the importance of Kv channel function 
to cardiac physiology is the robust association between cardiac arrhythmias with 
mutations in Kv channel subunit genes 133,134, as well as defective ventricular action 
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potential repolarization in mice lacking Kv proteins.135-137 The murine heart is known to 
express Kvβ1.1, Kvβ1.2, and Kvβ2 proteins.138 Kvβ1 associates primarily with proteins of 
the Kv4 family and loss of Kvβ1 reduces the abundance of Kv4.3 in the sarcolemma, 
blunts transient outward K+ current, and prevents modulation of action potential duration 
by changes in pyridine nucleotide redox state.138,139 The physiological role of Kvβ2 remains 
unclear. Considering that the heart expresses multiple Kvβ subtypes, it is plausible that 
the promiscuous association between both Kvβ1 and Kvβ2 proteins with Kv1 and Kv4 
channels contributes to priming cardiac Kv channels for modulation of channel 
inactivation. Under conditions of altered nucleotide redox (e.g., altered cardiac workload 
stress, ischemia), this influences the duration of the early and intermediate phases of 
repolarization of the action potential. 
The Kv channels expressed by vascular smooth muscle are a predominant 
regulator of vascular tone, and therefore control blood flow and organ perfusion.140 Kv1 
expression and function has been reported in a number of vascular beds, including 
coronary, pulmonary, mesenteric, and cerebral arteries, among others.141 Inhibition of Kv1 
channels induces vasoconstriction, suggesting that Kv1 channels are tonically active in 
vascular smooth muscle to oppose vascular tone development.142 However, little is known 
regarding the expression and function of Kvβ subunits in the vasculature. Our laboratory 
recently reported that murine coronary arterial myocytes express heteromeric assemblies 
of Kvβ complexes in association with Kv1.5 alpha subunits, and that genetic deletion of 
Kvβ2 reduces the membrane expression of Kv1.5 143, similar to that reported in neurons 
and heterologous expression systems.144,145 Although we and others have speculated that 
these subunits may play an important regulatory role in coupling tissue oxygen demand 
with vasodilatory function in various vascular beds 12,146,147, further research is needed to 
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increase our understanding of how the Kvβ proteins operate in the vasculature and how 
these may participate in functional or metabolic hyperemic responses.  
Unlike most peripheral arteries and arterioles, hypoxia causes rapid and profound 
vasoconstriction of pulmonary arteries.148 This phenomenon, referred to as “hypoxic 
pulmonary vasoconstriction” (HPV), is thought to be an important physiological response 
of the pulmonary circulation that shunts blood away from under-ventilated lung tissue.149 
However, excessive HPV can lead to pulmonary hypertension, right ventricular 
hypertrophy, and heart failure.150 Kv1 channels regulate pulmonary vascular smooth 
muscle membrane potential and mediate the HPV response.151,152 HPV is significantly 
impaired after genetic deletion of redox sensitive Kv1.5 channels, and in vivo gene transfer 
of Kv1.5 normalizes HPV in a model of chronic pulmonary hypertension.153,154 The 
association of the Kv1 channels of the pulmonary vasculature with Kvβ proteins may be 
integral to the HPV response. In support of this, bovine pulmonary arteries exhibit a 
significant increase in Kvβ1.1 expression with further progression towards higher order 
pulmonary arteries and arterioles.155 Higher expression of Kvβ1.1 may impart enhanced 
inactivation to Kv channels in small vessels in which HPV is apparent by allowing sensing 
of increases in NADH:NAD ratio upon a decrease in mitochondrial oxidative metabolism 
during periods of hypoxia.156 Nonetheless, the precise role of the Kvβ1 subunits in the 
HPV response has not been directly tested.  
 
Nervous system: Multiple types of Kv channels expressed in the central nervous system 
control membrane potential and excitability of neurons, and coordinate diverse processes 
such as action potential propagation and back propagation, neurotransmitter release, and 
apoptosis.157 The altered activity or expression of Kv channel proteins in the nervous 
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system has been associated with human pathological conditions such as epilepsy, 
multiple sclerosis, and Alzheimer’s disease.158-161 Neurons express multiple Kv alpha 
subunits that form functional channels, confer A-type K+ currents, and likely associate with 
Kvβ proteins, including dendritic Kv4.1, Kv4.2 and Kv4.3 subunits 162-164 and presynaptic 
Kv1.4 subunits.162 Variants of all three Kvβ gene products have been found in the brain, 
with Kvβ2 being the predominant form 165-171, suggesting that Kv1 and Kv4 channels may 
assemble into heteromers with considerable functional diversity that may participate in the 
determination of neuronal phenotype. In addition to modulation of channel activation and 
inactivation characteristics, Kvβ proteins may play a chaperone role and regulate the 
subcellular targeting of specific populations of Kv channels to distinct neuronal regions 
(i.e., axonal versus dendritic targeting).144,145 Genetic deletion of Kvβ2 in mice increases 
mortality, reduces body weight and results in defects in thermoregulatory processes 172, 
whereas mice lacking Kvβ1.1 have reduced Kv current inactivation, frequency-dependent 
spike broadening, and slower afterhyperpolarization compared with wild type mice. These 
changes in neuronal electrical signaling are associated with impaired learning and 
memory in water maze and social transmission tasks.173 Although definitive evidence is 
lacking, it is possible that changes in brain electrical activity could be strongly modulated 
by Kvβ-dependent regulation of Kv1 and Kv4 activity during periods of altered neuronal 
cytosolic redox potential, for example, changes in glucose metabolism.  
 
Endocrine and immune systems: Multiple Kv channel subtypes also participate in the 
physiological regulation of membrane potential in several cell types outside of the 
cardiovascular and nervous systems. Studies have suggested that these channels, via 
regulation of Ca2+ influx, also control hormonal secretion in cells of the endocrine system. 
For example, in pancreatic beta cells, an increase in Ca2+ influx following increased 
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cellular ATP:ADP ratio and inhibition of ATP-sensitive K+ channels (KATP) stimulates the 
release of insulin.161,174 Repolarization of the cell back to resting potential and cessation 
of the secretory process, is mediated, in part, by Kv-mediated outward K+ currents, which 
are likely mediated by a variety of Kv channel subtypes, including Kv1, Kv2, Kv4.175  
Although the expression profile of associated Kvβ proteins in pancreatic islets is not 
known, modulation of Kv activity by these subunits may be essential to proper electrical 
signaling following a glucose-induced rise in NADPH:NADP+ ratio in beta cells.176 In 
addition, Kv1 channels have also been shown to be expressed by cells of the immune 
system.57 Kv1.5 and Kv1.3 are the predominant Kvα proteins in macrophages and 
inhibition of Kv1 channels can prevent macrophage activation and proliferation.177-179 Bone 
marrow-derived macrophages express all known variants of Kvβ1, and Kvβ2.1 proteins 
180; LPS- and TNF-α induced activation differentially impact the abundance of these 
proteins and modify channel inactivation. This suggests that modification of Kv1 channel 
pore and auxiliary subunit composition may reflect an adaptive mechanism that could alter 
the functional properties of cells in the immune system. 
 
Therapeutic implications 
 Based on current knowledge of the physiological roles of Kvβ proteins, it is 
plausible that these proteins and their functional properties may represent an 
advantageous therapeutic target over conventional pharmacological ion channel blockers 
for several conditions. Classical inhibitors of AKRs show little inhibition of Kvβ-mediated 
catalysis, and currently, only a few pharmacological agents are known to impact Kvβ 
function; these act primarily as inhibitors of catalytic activity or by disrupting the 
association between the Kvβ and Kvα T1 docking domain. A recent study identified the 
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acidic dopamine metabolite 3,4-dihydroxphenylacetic acid (DOPAC) as an effective 
inhibitor of Kvβ2-mediated reduction of 4-nitrobenzaldehyde, inhibiting the production of 
4-nitrobenzyl alcohol by ~40% 181, albeit at supraphysiological concentrations. Additional 
nonendogenous inhibitors such as the cardioprotective drug resveratrol and plant derived 
flavonoid rutin, only slightly inhibit Kvβ2 catalytic activity by ~38% each. Alternatively, 
corticosteroids, such as cortisone, directly interact with Kvβ to increase Kv1 channel 
activity through binding near the cofactor binding pocket and the inter-subunit interface, 
resulting in dissociation of the Kvβ from the channel.182 There are currently no known 
pharmacological agonists that can selectively enhance Kvβ catalytic function. Further 
elucidation of compounds that can selectively modulate the function of the proteins may 
be valuable as novel therapeutics for the treatment of multiple disorders. Although the 
possibility for using compounds identified by these initial studies as Kvβ modulators as 
therapeutics is unlikely, they provide a useful foundation for further research into more 
beneficial chemical analogues that may possess more specific biological actions resulting 















The regulation of vasomotor control has been studied for over 100 years, however 
this system in an altered metabolic state has not been well established. Debate over what 
regulates vasomotor control to constrict or dilate vessels has continued since the first 
observations of endothelial and sarcolemmal mediated vasomotion.67 Over the last 
several decades mediators of vasomotor control during altered metabolism have been 
proposed and disproved or relegated as weak regulators. However, based on the literature 
and previous studies conducted by our laboratory and others, I have developed my 
present hypothesis to begin to investigate this mystery, it states: KVβ subunits functionally 
regulate resistance artery diameter. To address this hypothesis, we developed three key 
questions or sub-hypothesis; 1) Does deletion of either KVβ subunit alter vasoconstriction; 
2) Does deletion of either KVβ subunit affect vasodilation to stimuli that reflect an altered 
metabolic state; and finally, 3) Does catalytic activity (of the KVβ2 subunit) impact 














The imbalance between myocardial oxygen supply and demand is a salient 
pathophysiological feature of heart disease, which remains the leading cause of death 
worldwide.183 Insufficient myocardial perfusion is associated with cardiac dysfunction in 
patients with heart failure, hypertension, diabetes, and coronary artery disease.184-187  A 
discrepancy between oxygen supply and demand is commonly observed in patients with 
suppressed coronary vasodilator reserve—even in the absence of stenoses in large 
coronary arteries—likely due to the inability of small arteries and arterioles to respond to 
metabolic demand.188,189 Despite the vital importance of oxygen delivery to the 
preservation of cardiac function, the fundamental mechanisms by which the coronary 
vasculature responds to 
fluctuations in metabolic 
demand of the 
myocardium remain 
poorly understood. 
 In a healthy heart, the 
coronary arteries and 
arterioles operate in a 
partially constricted 
state of tone, such that dilation or constriction occurs depending on the need for oxygen 
Schematic 2 
 
Schematic 2: Proposed mechanism for KVβ mediated modification of KV channels in the 
presence of altered pyridine nucleotide redox ratio. The proposed differential response of KVβ-
subunits to an altered pyridine nucleotide redox ratio. For example, in the presence of increased NADH the 
tail of the KVβ1 complex inhibits the efflux of K+ via KV1.x channels; however, KVβ2 increases the efflux of 
K+ in the presence of increased NADH, inducing membrane hyperpolarization and inhibiting the inward flow 
of Ca+2 thus mediating vasodilation. By contrast, an increase in NAD+ would result in opposition of the 
example.  
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and nutrient delivery.8,190 As myocardial oxygen consumption increases (e.g., increased 
heart rate, myocardial contractility, or afterload), the heart requires instantaneous 
increases in oxygen supply to sustain oxidative energy production by the cardiomyocytes. 
With little reserve for increased oxygen extraction, sustained cardiac function relies on the 
intimate link between local and regional metabolic activity and vasodilation of the coronary 
vascular bed to deliver adequate blood flow to the active myocardium (i.e., metabolic 
hyperemia).191 In searching for the molecular entities coupling vascular function with 
myocardial metabolism, recent studies from our group56,192 and others193 have indicated 
that acute increases in cardiac work promote coronary vasodilation and hyperemia via 
activation of smooth muscle voltage-gated K+ channels belonging to the Kv1 family. 
Nonetheless, how vascular Kv1 channels sense changes in myocardial oxygen demand 
to regulate blood flow to the heart is unknown. Furthermore, the molecular contributions 
of the Kv1 channel subunits complex composition and whether these functionally 
contribute to metabolic hyperemia in the heart has not yet been determined. Based on the 
literature, and our own data presented here, we posit a physiological role for the KV1 
channels and their β-subunits as mediators of the arterial hyperemic response. 
In this study, we tested the hypothesis that vascular function is regulated by the 
intracellular auxiliary Kvβ proteins. As discussed in c. part 2, the Kvβ proteins are 
members of the aldo-keto reductase (AKR) superfamily and differentially regulate Kv1 
function upon changes in cellular redox status, thus representing a plausible link between 
metabolic activity and membrane excitability that can influence vasoreactivity. The 
mammalian genome contains three genes encoding Kvβ proteins, which are expressed in 
coronary arterial myocytes of humans194 and rodents.143 Our previous work indicated the 
presence of Kvβ heteromers of Kvβ1.1 and Kvβ2 in native Kv1.5 channels of coronary 
arterial myocytes.143 Using a combination of genetically engineered animals with ex vivo 
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and in vivo approaches, we report that vasoreactivity is controlled by the contrasting 





















MATERIALS AND METHODS 
Animals 
All animal procedures were conducted as approved by Institutional Animal Care and Use 
Committees at the University of Louisville. Experiments were conducted using age-
matched mice and littermates when possible. Additionally, Kvβ1.1-/- and Kvβ2-/- mice 114,173 
and strain-matched wild type (C57Bl/6N and 129/SvEv, respectively) mice (25-30 g body 
mass) were bred in house and fed ad libitum normal rodent chow. Transgenic animals 
were generated (Cyagen) with mouse Kcnab1 (NM_01059734) as the control of the 
tetracycline responsive element (TRE, 2nd generation) promoter (TRE-Kcnab1.1). 
Hemizygous TRE-Kcnab1.1 mice were bred to transgenic mice with the reverse 
tetracycline transactivator under the control of the murine SM22-alpha (SM22α or 
transgelin) promotor (SM22α-rtTA; Jackson Laboratories, stock no. 006875, FVB/N-Tg 
(Tagln-rtTA)E1Jwst/J)195 to yield double hemizygous SM22α-rtTA:TRE-Kcnab1.1 and 
littermate single transgenic SM22α-rtTA controls. Male mice (aged 3-6 months) were used 
for the study. All animals were housed in a temperature-controlled room on a 12:12 
light:dark cycle with ad libitum access to food and water. Mice were euthanized by 
intraperitoneal injection of sodium pentobarbital (150 mg∙kg-1) and thoracotomy and 
tissues were excised immediately for ex vivo functional measurements and biochemical 
assessments. 
Chemicals 
U46619 (CAS#: 56985-40-1), psora 4 (CAS#: 724709-68-6) was purchased from 
Tocris Bioscience (Tocris Bioscience, Bristol, United Kingdom). Chemicals purchased 
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from Sigma-Aldrich (St. Louis, Missouri, US) include: D-glucose (CAS#: 50-99-7), 
NaHCO3 (CAS#: 144-55-8), sodium chloride (CAS#: 7647-14-5), calcium chloride (CAS#: 
10043-52-4), magnesium chloride (CAS#: 7786-30-3), HEPES (CAS#: 7365-45-9), 
potassium chloride (CAS#: 7447-40-7), potassium phosphate monobasic (CAS#: 7778-
77-0), sodium lactate (CAS#: 867-56-1), nifidepine (CAS#: 21829-25-4), and forskolin 
(CAS#: 66575-29-9). We used a Sartorius Arium mini water system (Sartorius Lab 
Instruments GmbH & Co., Goettingen, Germany).  
Arterial diameter measurements 
 Third and fourth order branches of mesenteric and first and second order left anterior 
descending coronary arteries were dissected and kept in ice-cold isolation buffer 
consisting of (in mM): 134 NaCl, 6 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES, 7 D-glucose, pH 
7.4. Isolated arteries were used for arterial diameter measurements within 8 h after 
dissection. Isolated arteries were cleaned of connective tissue and cannulated on glass 
micropipettes mounted in a linear alignment single vessel myograph chamber (Living 
Systems Instrumentation, St. Albans, VT, USA). For a set of experiments, the vascular 
endothelium was functionally ablated by passage of air through the lumen (~30 s) during 
the cannulation procedure. After cannulation, the chamber was placed on an inverted 
microscope and arteries were equilibrated at 37°C and intravascular pressure of 20 
mmHg, maintained with a pressure servo control unit (Living Systems Instrumentation, St. 
Albans, VT, USA) under continuous perfusion (3-5 ml∙min-1) of physiological saline 
solution (PSS) consisting of (in mM): 119 NaCl, 4.7 KCl, 1.2 KH2PO4, 1.2 MgCl2, 7 D-
glucose, 24 NaHCO3, 2 CaCl2, maintained at pH 7.35-7.45 by aerating with 5% CO2, 20% 
O2, balance N2.  
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Following an equilibration period (45-60 min), lumenal diameter was continuously 
monitored and recorded with a charge coupled device (CCD) camera and edge detection 
software (IonOptix, Milton, MA, USA). Experiments were performed to examine effects of 
step-wise increases in intravascular pressure (20-100 mmHg), elevated [K+]o (via 
isosmotic replacement of KCl for NaCl), the synthetic thromboxane A2 analogue U46619 
(Tocris Bioscience, Minneapolis, MN, USA), adenosine (Sigma Aldrich, St. Louis, MO, 
USA), or L-lactate (Sigma Aldrich, St. Louis, MO, USA). For a set of experiments, hypoxic 
bath conditions were generated by perfusion of 1 mM Na2S2O4-containing PSS that was 
aerated with 5% CO2 (balance N2). Bath O2 levels were measured using a dissolved 
oxygen meter (World Precision Instruments, Sarasota, FL, USA). At the end of each 
experiment, the maximum passive diameter was measured in the presence of Ca2+-free 
PSS containing the L-type Ca2+ channel inhibitor nifedipine (1 μM) and adenylyl cyclase 
activator forskolin (0.5 μM), as described previously.196,197 Vasoconstriction is expressed 
as a decrease in arterial diameter relative to the maximum diameter at a given 
intravascular pressure. Changes in diameter (e.g., vasodilation) are normalized to 
differences from baseline and maximum passive diameters for each experiment. 
Statistics 
Data are presented as mean ± SEM. Data were analyzed using GraphPad Prism software 
using paired or unpaired Student’s t-tests, and Mann Whitney U and Wilcoxon signed rank 
non-parametric tests for comparisons of two experimental groups. One-way and two-way 
analysis of variance or non-parametric tests with Tukey post-hoc tests were used for 
comparisons of multiple groups and repeated measures datasets, as indicated in Figure 







Lactate induced vasodilation in mesenteric and coronary arteries 
 The vasoreactivity to lactate (a byproduct of increased cellular metabolism that is 
converted by the lactate dehydrogenase enzyme to pyruvate and increases the NADH to 
NAD+ ratio) was compared between mesenteric and left anterior descending coronary 
arteries from WT and KVβ2-/- mice Figure 1 (A, B). As indicated in the representative 
traces Figure 1 (A, B), increasing concentrations of lactate (5-20 mM) induced dilation. 
This response is summarized in Figure 1 (G, H). I investigated the role of the KV1 
channel in mediating vasodilation in response to vasoactive compounds (e.g., lactate), we 
first perfused the vasoactive compound (lactate) at several concentrations (5-20 mM) in 
the absence and presence of known general KV1 channel inhibitor Psora-4. As indicated 
in Figure 1 (A, B) 15 mM lactate induced vasodilation in both mesenteric and coronary 
arteries and addition of Psora-4 (C, D) ablated the vasodilation response. To assess the 
potential role of KVβ-subunits in KV1 channel mediated vasodilation in response to lactate, 
measurements of intralumenal diameter were obtained from freshly isolated mesenteric 
arterioles pressurized at 80 mmHg. Arteries were preconstricted (100 nM U46619) and 
perfused increasing concentrations of lactate (5-20 mM). In mesenteric and coronary 
arteries isolated from WT mice we observed that when 20 mM lactate was perfused into 
the bath arteries dilated and this was significantly reduced with addition of the Kv1-channel 
inhibitor Psora-4 (100 nM) (Figure 1A, B and C, D, respectively). However, in arteries 
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from KVβ2-/- mice demonstrates lactate (15 and 20 mM) induced vasodilation was 




























Figure 1. KV1 channels mediate lactate induced vasodilation in small resistance arteries. (A, B, C, D, E, F) 
Representative traces of arterial diameter recordings of pressurized (80 mmHg) thromboxane A2 analogue preconstricted 
(100 nM U4661) mesenteric and left anterior descending (LAD) coronary arteries from WT (± psora4), and KVβ2-/- mice 
before and after perfusion of sodium lactate (5-20 mM). Each experiment was concluded with the addition of Calcium free 
PSS (Ca2+-free), 1 µM nifedipine (nifed), and 500 nM forskolin (fsk)  (n = 5 and 4 arteries mesenteric and coronary 
respectively; N = 5 and 4 mice, mesenteric and coronary, respectively; * = P<0.05). (G, H) Summary of lactate induced 


























































































































































































Myogenic tone development is independent of changes to the KVβ-subunit complex 
composition. 
 Regulation of blood flow is tightly controlled by the ability of small resistance 
arteries (~100-300 µm)8 to develop myogenic tone and thus regulate vascular resistance.8 
Myogenic tone development is an autoregulatory mechanism meant to maintain a 
constant flow of blood through resistance arteries. We stepwise increased intravascular 
pressure through the physiological range (i.e., 60-100 mmHg). Representative traces of 
arteries from KVβ1-null (KVβ1-/-),  KVβ2-null (KVβ2-/-) and their respective wildtypes show 
that ablation of either KVβ-subunit did not impair myogenic tone development (Figure 1A). 
For example, at 80 mmHg, arteries from KVβ1-/- mice (Figure 2B) and KVβ2-/- and 
constricted like their respective wildtypes (Figure 2C). Summary graphs show at each 
pressure the passive diameters, relative to 0 mmHg, are not different between KVβ1-/-, 
KVβ2-/- and respective matched wild types (Figure 2D). These data support the conclusion 
that ablation of either KVβ-subunits does not significantly impact the mechanisms that 
mediate the development of myogenic tone. Furthermore, these data also verify that the 
method of knocking out of the KVβ-subunits does not impact this mechanism of vascular 












Figure 2. Myogenic tone development is independent from changes to the KVβ-subunit complex composition.
 (A) Representative arterial diameter recordings obtained from arteries isolated from WT (129SvEv), Kvβ1.1-/-, and 
Kvβ2-/- mice across a range of intravascular pressures, as indicated. Maximum passive diameters, obtained in Ca2+-free 
bath solution containing 100 nM nifedipine, are shown for each (dashed traces). (B, C) Bar graphs showing summarized % 
decrease in diameter at each intravascular pressure tested for arteries isolated from WT (n = 4 arteries from 4 mice) and 
Kvβ1.1-/- (D, n = 5 arteries from 5 mice) mice (D), and WT (n = 6 arteries from 5 mice) and  Kvβ2-/- (n = 6 arteries from 5 
mice) (P>0.05 at each pressure, respectively (Mann-Whitney U). (D) Summary of passive diameters relative to diameters 
at 0 mmHg across the range of intravascular pressures tested for arteries isolated from Kvβ1.1-/- (n = 5 arteries from 5 mice), 
Kvβ2-/- (n = 6 arteries from 5 mice), and corresponding WT controls (n = 4 arteries from 4 mice; n = 6 arteries from 5 mice) 
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Vasoconstriction response in resistance arteries is not impacted by loss of KVβ subunits. 
 Changes in membrane potential regulate the flow of ions across the membrane, 
as in the case of Ca2+ increased inward flow modulates greater vasoconstriction.198 The 
influx of Ca2+ is tightly regulated by efflux of K+ ions which mediate hyperpolarization of the 
cell membrane and prevent opening of voltage gated Ca2+ channels (Schematic 2). To 
assess whether ablation of KVβ-subunits, KVβ1-/- or KVβ2-/-, modifies the 60 mM K+ induced 
vasoconstriction we utilized freshly isolated small resistance arterioles from KVβ1-/- and 
KVβ2-/- mice and their respective wildtypes. Introduction of high potassium (>60 mM 
potassium) inhibits outward potassium flow effectively clamping membrane potential to 
the Nernst potential depolarizing the membrane, opening voltage gated calcium channels, 
and inducing vasoconstriction. In response to 60 mM K+, arteries isolated from KVβ1-/- and 
WT constricted, respectively (Figure 3A, B). Similarly, in KVβ2-/- and WT, arteries 
constricted, respectively (Figure 3C, D). We also examined whether the thromboxane A2 
mediated vasoconstrictive response was affected by ablation of either KVβ1-/- or KVβ2-/-. 
Representative traces from arteries perfused with the thromboxane A2 analogue U46619 
(100 nM) constricted similarly between KVβ1-/- and KVβ2-/- and their respective strain 
matched wildtypes (Figure 3C, D). From these data, we can conclude that ablation of 
individual KVβ-subunits (KVβ1-/- and KVβ2-/-) does not significantly impact mechanisms of 










Figure 3. Vasoconstriction response in resistance arteries is not impacted by loss of either Kvβ subunits. (A, B) 
Representative arterial diameter recordings obtained from pressurized (20 mmHg) mesenteric arteries before and after 
application of 60 mM external K+ (indicated by arrows; A), and summary of 60 mM K+-induced constriction (% decrease in 
diameter, B) in arteries isolated from Kvβ1.1-/- (n = 5 arteries from 5 mice), Kvβ2-/- (n = 5 arteries from 4 mice), and strain-
matched WT controls (C57Bl6N for Kvβ1.1-/-, n = 4 arteries from 4 mice; 129SvEv for Kvβ2-/-; n = 6 arteries from 5 mice). 
P=0.41 and. 0.43, respectively; Mann-Whitney U test. (C, D) Representative arterial diameter recordings from arteries (80 
mmHg) before and after application of 100 nM U46619 (indicated by arrows, C), and summary of U46619-induced 
constriction (% decrease in diameter, D), from groups as described in B. WT (C57Bl6N): n = 11 arteries from 10 mice; 
Kvβ1.1-/-: n = 11 arteries from 11 mice, WT (129SvEv): n = 10 arteries from 9 mice; Kvβ2-/-: n = 10 arteries from 10 mice. P-












































































Adenosine-induced vasodilation is not affected by knockout of KVβ-subunits 
 Adenosine is a potent vasodilator, which acts via A2A/2B to activate the GS protein 
to stimulate adenylate cyclase and increase intracellular cyclic adenosine monophosphate 
(cAMP).199 Therefore, in order to assess adenosine induced dilation in the absence of 
specific KVβ-subunits, we perfused increasing concentrations of adenosine onto isolated 
arteries from KVβ-subunit null (KVβ1-/- or KVβ2-/-) and wildtype mice. Our data show that at 
10-5M, adenosine-induced vasodilation is not significantly different between KVβ1-/- or WT 
(Figure 4A, B). Similarly, adenosine induced similar vasodilation in isolated arteries from 




















Figure 4. Adenosine-induced vasodilation is not affected by knockout of KVβ-subunits. Adenosine induced similar 
vasodilation in KVβ-null and respective wildtypes. At 10 µM adenosine induced vasodilation is not significantly different 
between KVβ1-/- or wildtype (n = 6, 5; N = 6, 4). Similarly, adenosine induced similar vasodilation in KVβ2-/- and wildtype (n 










































Lactate-induces vasodilation independent of endothelial function 
 The endothelium is considered a key mediator of vasodilation. Lactate could elicit 
vasodilation via production of endothelium-derived relaxation factors (e.g., H2O2). 
However, we investigated whether the endothelium mediates vasodilation in response to 
lactate by comparing endothelial intact and denuded vessels. To confirm inactivation (i.e., 
denudation) of the endothelium we used the SKCa/IKCa opener NS309, which induces 
endothelial dependent vasodilation. Figure 5 (A) shows representative traces of intact 
and endothelium-denuded (-endo) mesenteric arteries in the presence of the SKCa/IKCa 
opener NS309 (1 µM) to confirm loss of function in denuded vessels. The summary data 
of these experiments (Figure 5B) display loss of NS309 induced dilation. Figure 5 (C) 
shows representative traces of intact and denuded vessels that both dilated to 
approximately 20%  in the presence of 10 mM lactate. These summary data (Figure 5D) 
reveal that lactate induced similar levels of vasodilation in both intact and denuded arteries 
indicating that the mechanism of lactate-induced vasodilation is independent of 















Figure 5: Lactate induced vasodilation independent of endothelial function. (A) Arterial diameter recordings from 
preconstricted (100 nM U46619) intact and endothelium-denuded (- endo) in the absence and presence of the SKCa/IKCa 
opener NS309 (1 µM). (B) Summary graph showing 1 uM NS309 induced dilation (%) ± SEM in WT arteries with either an 
intact or denuded endothelium. n= 5 and 7 arteries from 5 and 4 mice.  P = 0.056 (Mann-Whitney U test). (C) Representative 
recordings of arterial diameter from preconstricted (100 nM U46619) WT intact and - endo arteries in the presence of 10 
mM lactate. (D) Summary bar graph of lactate induced dilation (%) ± SEM in WT intact and - endo arteries. n = 5 and 6 













Overexpression of KVβ1.1 impairs lactate induced vasodilation 
  Ablation of KVβ1.1 did not impact lactate induced vasodilation as compared to the 
respective wildtype Figure 6 A. However, vasodilation was significantly blunted in isolated 
arteries in response to extracellular L-lactate when compared with arteries from single 
transgenic control mice (Fig. 6 C, D). The overexpression of Kvβ1 emulates the observed 
response to lactate in arteries from Kvβ2-/- mice (Fig. 1 E, F). These data indicate a 
dynamic difference in the role of the Kvβ-subunits in responding to stimuli (e.g., lactate) 





















Figure 6. Increasing the ratio of Kvβ1.1:Kvβ2 subunits in smooth muscle , not knockout of Kvβ1.1 (Kvβ1.1-/-),  inhibit 
L-lactate-induced vasodilation. (A, B) Summarized data of Kvβ1.1-/- and SM22α-rtTA:TRE-β1 arteries perfused with 
increasing concentrations of L-lactate (5-20 mM) as compared to the respective wildtypes. (C, D) Representative arterial 
diameter recordings from 100 nM U46619-preconstricted mesenteric arteries isolated from SM22α-rtTA and SM22α-
rtTA:TRE-β1 mice in the absence and presence of L-lactate (5-20 mM), as in Figure 5 B. Passive dilation in the presence 
of Ca2+-free solution + nifedipine (1 μM) and forskolin (fsk; 0.5 μM) is shown for each recording. Kvβ1-/-: n = 7 arteries from 
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Association and expression of KV1.2, KV1.5, KVβ1 and KVβ2 are similar in vascular smooth 
muscle cells isolated from coronary and mesenteric arteries 
 The distribution of ion channels, and other proteins expressed in the vasculature 
are not consistently distributed across vascular beds. It is essential to show the expression 
and colocalization of the KV complex composition is consistent across resistance 
vasculature beds. In Figure 7 (A) Both, coronary and mesenteric vascular smooth muscle 
cells have similar colocalization of the vascular KV channel complexes (i.e., KV1.2, KV1.5, 
KVβ1 and KVβ2). These data are summarized in Figure 7 (B), indicating no significant 
difference between coronary and mesenteric myocytes colocalization of KV1.2, KV1.5, 



















Figure 7. Coronary and mesenteric arterial myocytes colocalization of KV1.2, KV1.5, KVβ1 and KVβ2. (A) Proximity 
ligation (PLA) experiments show similar localization of KV1.2, KV1.5, KVβ1 and KVβ2 (red foci) in isolated myocytes 
(membrane surface outlined with dots) from both coronary (left) and mesenteric (right) arteries (nucleus visualized in blue 
using DAPI) (all scale bars represent 5 µm reference). (B) Summarized data of PLA (n = 3) experiments showing no 
















































Ablation of KVβ1.1 did not significantly impact hypoxia induced vasodilation 
 Hypoxia occurs when O2 saturation drops below 20% and induces the vasodilatory 
response. Based on the different responses observed in KVβ1-/- and KVβ2-/- arteries, we 
proposed that hypoxia induced vasodilation response would be abolished in the absence 
of the KVβ2 subunit. Using the knockout mice, described above, we examined the effect 
of KVβ-subunit ablation on the hypoxia response in coronary arteries. Representative 
traces (Figure 8 A) show dilation in response to hypoxia in KVβ1-/- and their respective 
wildtype. However, in Figure 8 (C) hypoxia induced dilation does not occur in KVβ2-/- 
arteries, but it does in the respective wildtype. These experiments are graphically 













Figure 8  
 
Figure 8. Ablation of KVβ2 not KVβ1.1 significantly diminishes hypoxia induced vasodilation. (A) Representative 
myography trace of hypoxia induced vasodilation in arteries from WT (left, black) and KVβ1.1-/- (right, blue) mice. (B) 
Summary graph of hypoxia induced dilation in WT and KVβ1.1-/- arteries, respectively (P-value >0.5). (C) Ablation of KVβ2 
(right, red) significantly abolished hypoxia induced vasodilation as compared to wildtype (grey, left). (D) Summary graph of 



















































































































































KVβ2 catalytic function is necessary for lactate induced vasodilation 
 The KVβ subunits are members of the aldo-keto reductase (AKR) family and is 
important in the reduction of carbonyls. The KVβ2 subunit retains pyridine nucleotide 
binding pockets that are conserved throughout the AKR family.95 The point mutation of the 
KVβ2 subunit at the tyrosine in the 90th position to a phenylalanine abolishes the acid-base 
catalytic functionality of the subunit.122 The Y90F point mutation abolishes the KVβ2 























Figure 9. Catalytically inactive KVβ2 point mutant (KVβ2Y90F) abolishes lactate induced vasodilation. (A) 
Representative trace of arterial diameter from mesenteric arteries from wild type and KVβ2Y90F mice in the presence of 
lactate (5-20 mM) and passive dilation in the presence of Ca2+ free PSS with 1uM nifedipine and 500 nM forskolin (n = 5 
and 4, respectively). (B) Summary graph of percent (%) change in diameter comparing wildtype and KVβ2Y90F dilation to L-


















































Figure 10. KV1 mediated vasodilation in response to elevated L-lactate requires catalytically functional KVβ2. (A) 
Increased lactate is converted to pyruvate and NADH+ (B) via the lactate dehydrogenase enzyme. (C) In the absence of  
KVβ2 (green), the KVβ1 (yellow) subunit predominates and in the presence of lactate and vasoconstriction occurs. (D) The 
catalytically inactive KVβY90F (blue) abolishes lactate induced vasodilation. (E) Catalytically functional KVβ2 (green) is 






























Here we have identified the Kvβ proteins as functional regulators of vascular tone 
and further implicate divergent functional roles for Kvβ1 and Kvβ2 in the regulation of 
metabolic coronary hyperemia. The following key findings support these conclusions: 1) 
resistance arteries from Kvβ-null (Kvβ1.1-/-, Kvβ2-/-) mice exhibit normal vasoreactivity to 
increases in intravascular pressure, elevated external K+, and thromboxane receptor 
agonism; 2) vasodilation in response to L-lactate is abolished upon treatment with Kv1-
selective inhibitors and point mutation to or genetic ablation of Kvβ2 (KVβ2Y90F and KVβ2-/-
, respectively), but not Kvβ1.1 proteins; and 3) that the KVβ-subunits function similarly in 
varying resistance vasculature beds (e.g., mesenteric and coronary) (Figure 10). Thus, 
our results collectively support the concept that the predominant Kv1 auxiliary subunits, 
Kvβ1.1 and Kvβ2, function to cooperatively control vasodilation upon changes in metabolic 
demand. 
Kvβ proteins of the AKR6 family of aldo-keto reductases are catalytically active 
hydrophilic proteins that form heterotetrameric complexes at the cytosolic domain of native 
voltage-gated potassium channels in excitable cell types throughout the cardiovascular, 
nervous, endocrine, and immune systems.114 By the non-selective binding of a wide range 
of carbonyl substrates, these proteins catalyze the NAD(P)H-dependent reduction of a 
variety of endogenous aldehydes and ketones to primary and secondary alcohols.139,156 
Through differential regulation of channel activation and inactivation properties as a 
function of pyridine nucleotide redox status115, these proteins may participate in numerous 
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physiological processes by coupling outward K+ current and membrane excitability with 
intermediary metabolism.126 Despite nearly two decades of research on these intriguing 
proteins, further experimentation is necessary to fully elucidate how distinct Kvβ proteins 
perform unique and cell-specific roles in different organ systems. 
The tight regulation of blood flow is crucial to ensure blood pressure, and organ 
perfusion are maintained. Here, we report a physiologically relevant mechanism of 
vasodilatory control in small resistance arteries mediated via the KV1 channel β-subunit 
complex composition in response to altered metabolic demand that shifts substrates (e.g., 
NADH etc.) redox ratio.115 Our data demonstrate that the KV1-KVβ-subunit complex is 
sensitive to lactate, which in turn induces a physiological response i.e., vasodilation. This 
effect is abolished in the absence of the KVβ2 subunit or with loss of its catalytic function 
(KVβ2Y90F). Additionally, our present work demonstrates that vasoconstriction (e.g., 60 mM 
K+, and myogenic tone development) are not affected by changes to the KVβ-subunit 
complex composition. Moreover, our data establish that lactate-induced vasodilation is a 
response that acts independent of endothelial function and requires changes in the 
vascular smooth muscle cell membrane potential. My data show that the KVβ2 subunit  
mediating KV1 directed vasodilation.      
 Voltage-gated K+ channels expressed in excitable cells assemble as heteromeric 
structures, with mixed compositions of pore-forming Kv1.x α subunits forming functional 
channels with varied auxiliary subunit complexes. This ‘mix-and-match’ capability of Kv 
channels may contribute to the considerable heterogeneity of K+ currents that enable 
diverse physiological functions across a range of cell types. While our previous work found 
that Kv1.5 channels in murine coronary arterial myocytes interact with Kvβ1.1/Kvβ2 
heteromers,143 a key finding of the current study is the divergent functional regulation of 
vascular tone by these proteins. Ablation of only Kvβ2 suppressed vasodilatory function, 
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while ablation of Kvβ1.1 had little impact on vasodilation. These findings thus lead to the 
question of the specific physiological role of Kvβ1.1 in the vasculature. Our data suggest 
that the function of Kvβ2 is predominant. While the reasons for this discrepancy require 
further inquiry, previous work has shown that Kvβ2 can inhibit the N-terminal inactivation 
function of Kvβ1,130 either by competing for binding with pore-forming Shaker subunits, or 
through biophysical modification of Kvβ1 function via Kvβ-β interactions. It should also be 
noted that although Kvβ-subunit proteins are expressed in native Kv1 channels in the 
vasculature, we cannot infer absolute subunit ratios in native Kv1 populations from our 
data. Thus, considering that these proteins are present in Kv1 channels in smooth muscle 
cells of wild type mice under normal conditions, it is plausible that the prevalence of Kvβ2 
in Kv1 channels underlies the predominance of its functional importance under 
physiological conditions. Nonetheless, our data also support the notion that conditions that 
promote adaptive K+ channel remodeling towards elevated functional expression of 
Kvβ1.1:Kvβ2 may likely have profound effects on vascular reactivity and blood flow 
regulation.    
 Although our study indicates the involvement of Kvβ proteins in the regulation of 
vasodilation, the upstream endogenous signals that contribute to this phenomenon are 
unclear. Intriguingly, the Kvβ proteins were discovered as members of the aldo-keto 
reductase superfamily of oxidoreductases and are functional enzymes that catalyze the 
reduction of carbonyl compounds to alcohols.104,122 Hence, the Kvβ proteins each consist 
of a conserved AKR active site with nucleotide binding domain for nicotinamide cofactor 
hydride transfer. Later studies from our group and others demonstrating that the redox 
state of bound pyridine nucleotide differentially modifies channel activation and 
inactivation properties lead to the proposal that the Kvβs might serve as a critical link 
between cellular metabolic state and membrane excitability to control diverse functions in 
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excitable cells types.125,126,200 Based on the results of these studies and data presented 
here, further studies are needed to determine whether changes in pyridine nucleotide 
redox status in arterial myocytes underlie Kvβ-mediated control of blood flow in the heart 
upon changes in metabolic demand.  
Based on the data presented here we can conclude that: 1) lactate induced 
vasodilation is mediated by the KV1 channel and requires the catalytically functional KVβ2 
subunit; 2) ablation of either KVβ-subunit does not impact pressure induced myogenic tone 
development; 3) ablation of either subunit does not significantly impair the vasoconstrictor 
response to membrane depolarization or agonist induced constriction; 4) neither KVβ1 or 
KVβ2 appear to enhance or impair adenosine induced vasodilation; 5) lactate induced 
vasodilation is mediated independent of the endothelium; 6) overexpression of the Kvβ1 
subunit emulates the Kvβ2-/- condition; 7) coronary and mesenteric myocyte KV-channels 
have similar quantities of colocalized KV-α and KV-β components. These data support 
crucial functional roles for KVβ1 and Kvβ2 in modifying KV1 mediated arterial diameter in 
response to vasodilators. I have also provided evidence for the KVβ2 subunit, and its 
catalytic activity, as a sensor of altered metabolic demand that alters KV1 mediated 
vasodilation. Additionally, recently acquired unpublished data using electrophysiological 
patch clamp, conducted by graduate student Marc Dwenger, shows whole cell outward 
potassium currents increase significantly in the presence of lactate, and this is inhibited in 
the presence of Psora-4. Altogether, these data support a functional role for KVβ2 as a 
sensor, triggered by altered metabolic demand, that modifies KV1 mediated vasodilation.   
 The present study has several key limitations. One limitation is potential sex-based 
differences that may exist and differently affect the phenomenon we observe.201,202 To 
address this, future studies will conduct many of these experiments in age matched female 
mice to determine any potential sex-based differences. Additionally, the use of global 
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knockout murine models presents potential issues in other organ systems which may 
impact the resultant observed phenomenon. To address this issue, I will use tissue-
specific doxycycline inducible expression models, as described in the materials and 
methods section. When these mice are given water containing doxycycline (ad libitum) for 
ten days the reverse tetracycline trans-activator, driven by the SM22α promoter, increases 
smooth muscle specific expression of the associated β-subunit. Using these models 
should mitigate any affects observed in the global KVβ-knockout murine models. 
Additionally, the effects of aging on the cardiovascular system are not well understood 
and could result in a variable response to the phenomenon observed. To address this, 
future studies will compare differences in KVβ subunit expression and function in mice of 

































1 Zeiher, A. M., Krause, T., Schachinger, V., Minners, J. & Moser, E. Impaired endothelium-
dependent vasodilation of coronary resistance vessels is associated with exercise-induced 
myocardial ischemia. Circulation 91, 2345-2352, doi:10.1161/01.cir.91.9.2345 (1995). 
2 Duncker, D. J. & Bache, R. J. Regulation of coronary blood flow during exercise. Physiol 
Rev 88, 1009-1086, doi:10.1152/physrev.00045.2006 (2008). 
3 Groennebaek, T. et al. Effect of Blood Flow Restricted Resistance Exercise and Remote 
Ischemic Conditioning on Functional Capacity and Myocellular Adaptations in Patients 
With Heart Failure. Circ Heart Fail 12, e006427, 
doi:10.1161/CIRCHEARTFAILURE.119.006427 (2019). 
4 Yamauchi, H., Okazawa, H., Kishibe, Y., Sugimoto, K. & Takahashi, M. Reduced blood flow 
response to acetazolamide reflects pre-existing vasodilation and decreased oxygen 
metabolism in major cerebral arterial occlusive disease. Eur J Nucl Med Mol Imaging 29, 
1349-1356, doi:10.1007/s00259-002-0899-x (2002). 
5 Dai, L. et al. Hydrogen sulfide inhibited L-type calcium channels (CaV1.2) via up-regulation 
of the channel sulfhydration in vascular smooth muscle cells. Eur J Pharmacol 858, 
172455, doi:10.1016/j.ejphar.2019.172455 (2019). 
6 Ohanyan, V. et al. Myocardial Blood Flow Control by Oxygen Sensing Vascular Kvbeta 
Proteins. Circ Res, doi:10.1161/CIRCRESAHA.120.317715 (2021). 
7 Raph, S. M., Bhatnagar, A. & Nystoriak, M. A. Biochemical and physiological properties of 
K(+) channel-associated AKR6A (Kvbeta) proteins. Chem Biol Interact 305, 21-27, 
doi:10.1016/j.cbi.2019.03.023 (2019). 
8 Goodwill, A. G., Dick, G. M., Kiel, A. M. & Tune, J. D. Regulation of Coronary Blood Flow. 
Compr Physiol 7, 321-382, doi:10.1002/cphy.c160016 (2017). 
9 Duncker, D. J., Bache, R. J. & Merkus, D. Regulation of coronary resistance vessel tone in 
response to exercise. J Mol Cell Cardiol 52, 802-813, doi:10.1016/j.yjmcc.2011.10.007 
(2012). 
10 Knot, H. J. & Nelson, M. T. Regulation of arterial diameter and wall [Ca+2] in cerebral 
arteries of rat by membrane potential and intravascular pressure. Journal of Physiology 
508.1 (1998). 
11 Bliss, M. R. Hyperaemia. J Tissue Viability 8, 4-13, doi:10.1016/s0965-206x(98)80028-4 
(1998). 
12 Dwenger, M. M., Ohanyan, V., Navedo, M. F. & Nystoriak, M. A. Coronary microvascular 
Kv1 channels as regulatory sensors of intracellular pyridine nucleotide redox potential. 
Microcirculation 25, doi:10.1111/micc.12426 (2018). 
13 <Bayliss-1902-On-the-local-reactions-of-the-arter.pdf>. 
14 Knot, H. J. & Nelson, M. T. Regulation of membrane potential and diameter by voltage-
dependent K+ channels in rabbit myogenic cerebral arteries. American Journal of 
Physiology-Heart and Circulatory Physiology 269, H348-H355, 
doi:10.1152/ajpheart.1995.269.1.H348 (1995). 
59 
15 Falcone, J. C., Davis, M. J. & Meininger, G. A. Endothelial independence of myogenic 
response in isolated skeletal muscle arterioles. Am J Physiol 260, H130-135, 
doi:10.1152/ajpheart.1991.260.1.H130 (1991). 
16 McCarron, J. G., Osol, G. & Halpern, W. Myogenic responses are independent of the 
endothelium in rat pressurized posterior cerebral arteries. Blood Vessels 26, 315-319, 
doi:10.1159/000158780 (1989). 
17 Brayden, J. E. & Wellman, G. C. Endothelium-dependent dilation of feline cerebral 
arteries: role of membrane potential and cyclic nucleotides. J Cereb Blood Flow Metab 9, 
256-263, doi:10.1038/jcbfm.1989.42 (1989). 
18 Harder, D. R. Pressure-dependent membrane depolarization in cat middle cerebral artery. 
Circ Res 55, 197-202, doi:10.1161/01.res.55.2.197 (1984). 
19 Knot, H. J. & Nelson, M. T. Regulation of arterial diameter and wall [Ca2+] in cerebral 
arteries of rat by membrane potential and intravascular pressure. J Physiol 508 ( Pt 1), 
199-209, doi:10.1111/j.1469-7793.1998.199br.x (1998). 
20 Thorin-Trescases, N. et al. Diameter dependence of myogenic tone of human pial arteries. 
Possible relation to distensibility. Stroke 28, 2486-2492, doi:10.1161/01.str.28.12.2486 
(1997). 
21 Meininger, G. A. & Davis, M. J. Cellular mechanisms involved in the vascular myogenic 
response. Am J Physiol 263, H647-659, doi:10.1152/ajpheart.1992.263.3.H647 (1992). 
22 Hille, B. Ionic channels in excitable membranes. Current problems and biophysical 
approaches. Biophys J 22, 283-294, doi:10.1016/S0006-3495(78)85489-7 (1978). 
23 Wahlstrom, B. A. Ionic fluxes in the rat portal vein and the applicability of the Goldman 
equation in predicting the membrane potential from flux data. Acta Physiol Scand 89, 436-
448, doi:10.1111/j.1748-1716.1973.tb05539.x (1973). 
24 Hodgkin, A. L. & Katz, B. The effect of temperature on the electrical activity of the giant 
axon of the squid. J Physiol 109, 240-249, doi:10.1113/jphysiol.1949.sp004388 (1949). 
25 Hodgkin, A. L. & Katz, B. The effect of sodium ions on the electrical activity of giant axon 
of the squid. J Physiol 108, 37-77, doi:10.1113/jphysiol.1949.sp004310 (1949). 
26 Cole, K. S. & Hodgkin, A. L. Membrane and Protoplasm Resistance in the Squid Giant Axon. 
J Gen Physiol 22, 671-687, doi:10.1085/jgp.22.5.671 (1939). 
27 Hodgkin, A. L. & Huxley, A. F. Movement of radioactive potassium and membrane current 
in a giant axon. J Physiol 121, 403-414, doi:10.1113/jphysiol.1953.sp004954 (1953). 
28 Hodgkin, A. L. & Huxley, A. F. Currents carried by sodium and potassium ions through the 
membrane of the giant axon of Loligo. J Physiol 116, 449-472, 
doi:10.1113/jphysiol.1952.sp004717 (1952). 
29 Hodgkin, A. L. & Huxley, A. F. Movement of sodium and potassium ions during nervous 
activity. Cold Spring Harb Symp Quant Biol 17, 43-52, doi:10.1101/sqb.1952.017.01.007 
(1952). 
30 Huxley, A. F. & Stampfli, R. Effect of potassium and sodium on resting and action 
potentials of single myelinated nerve fibers. J Physiol 112, 496-508, 
doi:10.1113/jphysiol.1951.sp004546 (1951). 
31 Katz, B. & Lou, C. H. Contractibility of muscle in isotonic potassium salt solution. J Physiol 
106, 30 (1947). 
32 Miller, C. An overview of the potassium channel family. Genome Biol 1, REVIEWS0004, 
doi:10.1186/gb-2000-1-4-reviews0004 (2000). 
33 Johnston, J., Forsythe, I. D. & Kopp-Scheinpflug, C. Going native: voltage-gated potassium 
channels controlling neuronal excitability. J Physiol 588, 3187-3200, 
doi:10.1113/jphysiol.2010.191973 (2010). 
60 
34 Pardo, L. A. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 
19, 285-292, doi:10.1152/physiol.00011.2004 (2004). 
35 Jan, L. Y. & Jan, Y. N. Voltage-gated potassium channels and the diversity of electrical 
signalling. J Physiol 590, 2591-2599, doi:10.1113/jphysiol.2011.224212 (2012). 
36 Bichet, D., Haass, F. A. & Jan, L. Y. Merging functional studies with structures of inward-
rectifier K(+) channels. Nat Rev Neurosci 4, 957-967, doi:10.1038/nrn1244 (2003). 
37 Knot, H. J., Zimmermann, P. A. & Nelson, M. T. Extracellular K(+)-induced 
hyperpolarizations and dilatations of rat coronary and cerebral arteries involve inward 
rectifier K(+) channels. J Physiol 492 ( Pt 2), 419-430, doi:10.1113/jphysiol.1996.sp021318 
(1996). 
38 Sieber, F. E., Wilson, D. A., Hanley, D. F. & Traystman, R. J. Extracellular potassium activity 
and cerebral blood flow during moderate hypoglycemia in anesthetized dogs. Am J Physiol 
264, H1774-1780, doi:10.1152/ajpheart.1993.264.6.H1774 (1993). 
39 Babenko, A. P., Aguilar-Bryan, L. & Bryan, J. A view of sur/KIR6.X, KATP channels. Annu 
Rev Physiol 60, 667-687, doi:10.1146/annurev.physiol.60.1.667 (1998). 
40 Akatsuka, Y. et al. ATP sensitive potassium channels are involved in adenosine A2 receptor 
mediated coronary vasodilatation in the dog. Cardiovasc Res 28, 906-911, 
doi:10.1093/cvr/28.6.906 (1994). 
41 Haynes, J., Jr., Obiako, B., Thompson, W. J. & Downey, J. Adenosine-induced vasodilation: 
receptor characterization in pulmonary circulation. Am J Physiol 268, H1862-1868, 
doi:10.1152/ajpheart.1995.268.5.H1862 (1995). 
42 Liu, Y., Bubolz, A. H., Mendoza, S., Zhang, D. X. & Gutterman, D. D. H2O2 is the 
transferrable factor mediating flow-induced dilation in human coronary arterioles. Circ 
Res 108, 566-573, doi:10.1161/CIRCRESAHA.110.237636 (2011). 
43 Miura, H. et al. Role for hydrogen peroxide in flow-induced dilation of human coronary 
arterioles. Circ Res 92, e31-40, doi:10.1161/01.res.0000054200.44505.ab (2003). 
44 Miura, H. et al. Flow-induced dilation of human coronary arterioles: important role of 
Ca(2+)-activated K(+) channels. Circulation 103, 1992-1998, 
doi:10.1161/01.cir.103.15.1992 (2001). 
45 Richmond, K. N., Tune, J. D., Gorman, M. W. & Feigl, E. O. Role of K(ATP)(+) channels and 
adenosine in the control of coronary blood flow during exercise. J Appl Physiol (1985) 89, 
529-536, doi:10.1152/jappl.2000.89.2.529 (2000). 
46 Sausbier, M. et al. Elevated blood pressure linked to primary hyperaldosteronism and 
impaired vasodilation in BK channel-deficient mice. Circulation 112, 60-68, 
doi:10.1161/01.CIR.0000156448.74296.FE (2005). 
47 Krishnamoorthy-Natarajan, G. & Koide, M. BK Channels in the Vascular System. Int Rev 
Neurobiol 128, 401-438, doi:10.1016/bs.irn.2016.03.017 (2016). 
48 Filosa, J. A. et al. Local potassium signaling couples neuronal activity to vasodilation in the 
brain. Nat Neurosci 9, 1397-1403, doi:10.1038/nn1779 (2006). 
49 Khavandi, K. et al. Pressure-induced oxidative activation of PKG enables vasoregulation 
by Ca2+ sparks and BK channels. Sci Signal 9, ra100, doi:10.1126/scisignal.aaf6625 (2016). 
50 Jaggar, J. H., Porter, V. A., Lederer, W. J. & Nelson, M. T. Calcium sparks in smooth muscle. 
Am J Physiol Cell Physiol 278, C235-256, doi:10.1152/ajpcell.2000.278.2.C235 (2000). 
51 Nelson, M. T. et al. Relaxation of arterial smooth muscle by calcium sparks. Science 270, 
633-637, doi:10.1126/science.270.5236.633 (1995). 
52 Brenner, R. et al. Vasoregulation by the beta1 subunit of the calcium-activated potassium 
channel. Nature 407, 870-876, doi:10.1038/35038011 (2000). 
61 
53 Nieves-Cintron, M., Syed, A. U., Nystoriak, M. A. & Navedo, M. F. Regulation of voltage-
gated potassium channels in vascular smooth muscle during hypertension and metabolic 
disorders. Microcirculation 25, doi:10.1111/micc.12423 (2018). 
54 Bowles, D. K., Laughlin, M. H. & Sturek, M. Exercise training increases K+-channel 
contribution to regulation of coronary arterial tone. J Appl Physiol (1985) 84, 1225-1233, 
doi:10.1152/jappl.1998.84.4.1225 (1998). 
55 Nelson, M. T. Regulation of arterial tone by potassium channels. Jpn J Pharmacol 58 Suppl 
2, 238P-242P (1992). 
56 Ohanyan, V. et al. Requisite Role of Kv1.5 Channels in Coronary Metabolic Dilation. Circ 
Res 117, 612-621, doi:10.1161/CIRCRESAHA.115.306642 (2015). 
57 Feske, S., Wulff, H. & Skolnik, E. Y. Ion channels in innate and adaptive immunity. Annu 
Rev Immunol 33, 291-353, doi:10.1146/annurev-immunol-032414-112212 (2015). 
58 Simons, C. et al. Corrigendum: Mutations in the voltage-gated potassium channel gene 
KCNH1 cause Temple-Baraitser syndrome and epilepsy. Nat Genet 47, 304, 
doi:10.1038/ng0315-304b (2015). 
59 Kim, J. H. et al. The voltage-gated potassium channel Shaker promotes sleep via 
thermosensitive GABA transmission. Commun Biol 3, 174, doi:10.1038/s42003-020-0902-
8 (2020). 
60 Pongs, O. Voltage-gated potassium channels: from hyperexcitability to excitement. FEBS 
Lett 452, 31-35, doi:10.1016/s0014-5793(99)00535-9 (1999). 
61 Furchgott, R. F. Endothelium-derived relaxing factor: discovery, early studies, and 
identification as nitric oxide. Biosci Rep 19, 235-251, doi:10.1023/a:1020537506008 
(1999). 
62 Vallance, P., Collier, J. & Moncada, S. Effects of endothelium-derived nitric oxide on 
peripheral arteriolar tone in man. Lancet 2, 997-1000, doi:10.1016/s0140-
6736(89)91013-1 (1989). 
63 Dale, H. H. & Dudley, H. W. The presence of histamine and acetylcholine in the spleen of 
the ox and the horse. J Physiol 68, 97-123, doi:10.1113/jphysiol.1929.sp002598 (1929). 
64 Dudley, H. W. Observations on acetylcholine. Biochem J 23, 1064-1074, 
doi:10.1042/bj0231064 (1929). 
65 Kellogg, D. L., Jr., Zhao, J. L., Coey, U. & Green, J. V. Acetylcholine-induced vasodilation is 
mediated by nitric oxide and prostaglandins in human skin. J Appl Physiol (1985) 98, 629-
632, doi:10.1152/japplphysiol.00728.2004 (2005). 
66 Mott, F. W. & Halliburton, W. D. On the Physiological Action of Choline and Neurine. Br 
Med J 1, 1082-1083, doi:10.1136/bmj.1.2001.1082 (1899). 
67 Furchgott, R. F. & Zawadzki, J. V. The obligatory role of endothelial cells in the relaxation 
of arterial smooth muscle by acetylcholine. Nature 288, 373-376, doi:10.1038/288373a0 
(1980). 
68 Ignarro, L. J., Byrns, R. E., Buga, G. M. & Wood, K. S. Endothelium-derived relaxing factor 
from pulmonary artery and vein possesses pharmacologic and chemical properties 
identical to those of nitric oxide radical. Circ Res 61, 866-879, doi:10.1161/01.res.61.6.866 
(1987). 
69 Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. & Chaudhuri, G. Endothelium-derived 
relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad 
Sci U S A 84, 9265-9269, doi:10.1073/pnas.84.24.9265 (1987). 
70 Palmer, R. M., Ferrige, A. G. & Moncada, S. Nitric oxide release accounts for the biological 
activity of endothelium-derived relaxing factor. Nature 327, 524-526, 
doi:10.1038/327524a0 (1987). 
62 
71 Liu, Y. & Gutterman, D. D. Vascular control in humans: focus on the coronary 
microcirculation. Basic Res Cardiol 104, 211-227, doi:10.1007/s00395-009-0775-y (2009). 
72 Canty, J. M., Jr. & Schwartz, J. S. Nitric oxide mediates flow-dependent epicardial coronary 
vasodilation to changes in pulse frequency but not mean flow in conscious dogs. 
Circulation 89, 375-384, doi:10.1161/01.cir.89.1.375 (1994). 
73 Tang, W. H. W., Wang, Z. N., Cho, L., Brennan, D. M. & Hazen, S. L. Diminished Global 
Arginine Bioavailability and Increased Arginine Catabolism as Metabolic Profile of 
Increased Cardiovascular Risk. Journal of the American College of Cardiology 53, 2061-
2067, doi:10.1016/j.jacc.2009.02.036 (2009). 
74 Borysova, L. & Burdyga, T. Evidence that NO/cGMP/PKG signalling cascade mediates 
endothelium dependent inhibition of IP(3)R mediated Ca(2)(+) oscillations in myocytes 
and pericytes of ureteric microvascular network in situ. Cell Calcium 58, 535-540, 
doi:10.1016/j.ceca.2015.08.006 (2015). 
75 Sandoo, A., van Zanten, J. J., Metsios, G. S., Carroll, D. & Kitas, G. D. The endothelium and 
its role in regulating vascular tone. Open Cardiovasc Med J 4, 302-312, 
doi:10.2174/1874192401004010302 (2010). 
76 Lincoln, T. M. Cyclic GMP and mechanisms of vasodilation. Pharmacol Ther 41, 479-502, 
doi:10.1016/0163-7258(89)90127-7 (1989). 
77 Munzel, T., Steven, S. & Daiber, A. Organic nitrates: update on mechanisms underlying 
vasodilation, tolerance and endothelial dysfunction. Vascul Pharmacol 63, 105-113, 
doi:10.1016/j.vph.2014.09.002 (2014). 
78 Freed, J. K. & Gutterman, D. D. Communication Is Key: Mechanisms of Intercellular 
Signaling in Vasodilation. J Cardiovasc Pharmacol 69, 264-272, 
doi:10.1097/FJC.0000000000000463 (2017). 
79 Cooke, J. P. & Losordo, D. W. Nitric oxide and angiogenesis. Circulation 105, 2133-2135, 
doi:10.1161/01.cir.0000014928.45119.73 (2002). 
80 Kapil, V. et al. The Noncanonical Pathway for In Vivo Nitric Oxide Generation: The Nitrate-
Nitrite-Nitric Oxide Pathway. Pharmacol Rev 72, 692-766, doi:10.1124/pr.120.019240 
(2020). 
81 Altman, J. D., Kinn, J., Duncker, D. J. & Bache, R. J. Effect of inhibition of nitric oxide 
formation on coronary blood flow during exercise in the dog. Cardiovasc Res 28, 119-124, 
doi:10.1093/cvr/28.1.119 (1994). 
82 Bernstein, R. D. et al. Function and production of nitric oxide in the coronary circulation 
of the conscious dog during exercise. Circ Res 79, 840-848, doi:10.1161/01.res.79.4.840 
(1996). 
83 Duncker, D. J., Stubenitsky, R., Tonino, P. A. & Verdouw, P. D. Nitric oxide contributes to 
the regulation of vasomotor tone but does not modulate O(2)-consumption in exercising 
swine. Cardiovasc Res 47, 738-748, doi:10.1016/s0008-6363(00)00143-7 (2000). 
84 Jones, C. J., Kuo, L., Davis, M. J. & Chilian, W. M. Regulation of coronary blood flow: 
coordination of heterogeneous control mechanisms in vascular microdomains. 
Cardiovasc Res 29, 585-596 (1995). 
85 Vanhoutte, P. M. Endothelial control of vasomotor function: from health to coronary 
disease. Circ J 67, 572-575, doi:10.1253/circj.67.572 (2003). 
86 Fleming, I., Bauersachs, J. & Busse, R. Paracrine functions of the coronary vascular 
endothelium. Mol Cell Biochem 157, 137-145, doi:10.1007/BF00227892 (1996). 
87 Wang, M. et al. Involvement of Hydrogen Sulfide in Endothelium-Derived Relaxing Factor-
Mediated Responses in Rat Cerebral Arteries. J Vasc Res 53, 172-185, 
doi:10.1159/000448712 (2016). 
63 
88 Jones, C. J., DeFily, D. V., Patterson, J. L. & Chilian, W. M. Endothelium-dependent 
relaxation competes with alpha 1- and alpha 2-adrenergic constriction in the canine 
epicardial coronary microcirculation. Circulation 87, 1264-1274, 
doi:10.1161/01.cir.87.4.1264 (1993). 
89 Furchgott, R. F. & Vanhoutte, P. M. Endothelium-derived relaxing and contracting factors. 
FASEB J 3, 2007-2018 (1989). 
90 Kaw, S., Hecker, M. & Vane, J. R. The two-step conversion of big endothelin 1 to 
endothelin 1 and degradation of endothelin 1 by subcellular fractions from human 
polymorphonuclear leukocytes. Proc Natl Acad Sci U S A 89, 6886-6890, 
doi:10.1073/pnas.89.15.6886 (1992). 
91 Yoshida, M., Suzuki, A. & Itoh, T. Mechanisms of vasoconstriction induced by endothelin-
1 in smooth muscle of rabbit mesenteric artery. J Physiol 477, 253-265, 
doi:10.1113/jphysiol.1994.sp020188 (1994). 
92 Shimoda, L. A., Sham, J. S., Liu, Q. & Sylvester, J. T. Acute and chronic hypoxic pulmonary 
vasoconstriction: a central role for endothelin-1? Respir Physiol Neurobiol 132, 93-106, 
doi:10.1016/s1569-9048(02)00052-6 (2002). 
93 Peng, W., Michael, J. R., Hoidal, J. R., Karwande, S. V. & Farrukh, I. S. ET-1 modulates KCa-
channel activity and arterial tension in normoxic and hypoxic human pulmonary 
vasculature. Am J Physiol 275, L729-739, doi:10.1152/ajplung.1998.275.4.L729 (1998). 
94 Hoog, S. S., Pawlowski, J. E., Alzari, P. M., Penning, T. M. & Lewis, M. Three-dimensional 
structure of rat liver 3 alpha-hydroxysteroid/dihydrodiol dehydrogenase: a member of 
the aldo-keto reductase superfamily. Proc Natl Acad Sci U S A 91, 2517-2521 (1994). 
95 Barski, O. A., Tipparaju, S. M. & Bhatnagar, A. The aldo-keto reductase superfamily and its 
role in drug metabolism and detoxification. Drug Metab Rev 40, 553-624, 
doi:10.1080/03602530802431439 (2008). 
96 Bohren, K. M., Bullock, B., Wermuth, B. & Gabbay, K. H. The aldo-keto reductase 
superfamily. cDNAs and deduced amino acid sequences of human aldehyde and aldose 
reductases. J Biol Chem 264, 9547-9551 (1989). 
97 Trauger, J. W., Jiang, A., Stearns, B. A. & LoGrasso, P. V. Kinetics of allopregnanolone 
formation catalyzed by human 3 alpha-hydroxysteroid dehydrogenase type III (AKR1C2). 
Biochemistry 41, 13451-13459 (2002). 
98 Mindnich, R. D. & Penning, T. M. Aldo-keto reductase (AKR) superfamily: genomics and 
annotation. Hum Genomics 3, 362-370 (2009). 
99 Neuhauser, W., Haltrich, D., Kulbe, K. D. & Nidetzky, B. NAD(P)H-dependent aldose 
reductase from the xylose-assimilating yeast Candida tenuis. Isolation, characterization 
and biochemical properties of the enzyme. Biochem J 326 ( Pt 3), 683-692 (1997). 
100 Gulbis, J. M., Mann, S. & MacKinnon, R. Structure of a voltage-dependent K+ channel beta 
subunit. Cell 97, 943-952 (1999). 
101 Gulbis, J. M., Zhou, M., Mann, S. & MacKinnon, R. Structure of the cytoplasmic beta 
subunit-T1 assembly of voltage-dependent K+ channels. Science 289, 123-127 (2000). 
102 Nerbonne, J. M. Molecular basis of functional voltage-gated K+ channel diversity in the 
mammalian myocardium. J Physiol 525 Pt 2, 285-298 (2000). 
103 Philipson, L. H. Beta-cell ion channels: keys to endodermal excitability. Horm Metab Res 
31, 455-461, doi:10.1055/s-2007-978774 (1999). 
104 McCormack, T. & McCormack, K. Shaker K+ channel beta subunits belong to an NAD(P)H-
dependent oxidoreductase superfamily. Cell 79, 1133-1135 (1994). 
105 Penning, T. M. The aldo-keto reductases (AKRs): Overview. Chem Biol Interact 234, 236-
246, doi:10.1016/j.cbi.2014.09.024 (2015). 
64 
106 Gonzalez, C. et al. K(+) channels: function-structural overview. Compr Physiol 2, 2087-
2149, doi:10.1002/cphy.c110047 (2012). 
107 Doyle, D. A. et al. The structure of the potassium channel: molecular basis of K+ 
conduction and selectivity. Science 280, 69-77 (1998). 
108 Chung, S. H., Allen, T. W., Hoyles, M. & Kuyucak, S. Permeation of ions across the 
potassium channel: Brownian dynamics studies. Biophys J 77, 2517-2533, 
doi:10.1016/S0006-3495(99)77087-6 (1999). 
109 Sansom, M. S. et al. Potassium channels: structures, models, simulations. Biochim Biophys 
Acta 1565, 294-307 (2002). 
110 Long, S. B., Campbell, E. B. & Mackinnon, R. Voltage sensor of Kv1.2: structural basis of 
electromechanical coupling. Science 309, 903-908, doi:10.1126/science.1116270 (2005). 
111 Scott, V. E. et al. Antibodies specific for distinct Kv subunits unveil a heterooligomeric 
basis for subtypes of alpha-dendrotoxin-sensitive K+ channels in bovine brain. 
Biochemistry 33, 1617-1623 (1994). 
112 Coetzee, W. A. et al. Molecular diversity of K+ channels. Ann N Y Acad Sci 868, 233-285 
(1999). 
113 Pongs, O. & Schwarz, J. R. Ancillary subunits associated with voltage-dependent K+ 
channels. Physiol Rev 90, 755-796, doi:10.1152/physrev.00020.2009 (2010). 
114 McCormack, K. et al. Genetic analysis of the mammalian K+ channel beta subunit Kvbeta 
2 (Kcnab2). J Biol Chem 277, 13219-13228, doi:10.1074/jbc.M111465200 (2002). 
115 Kilfoil, P. J., Tipparaju, S. M., Barski, O. A. & Bhatnagar, A. Regulation of ion channels by 
pyridine nucleotides. Circ Res 112, 721-741, doi:10.1161/CIRCRESAHA.111.247940 
(2013). 
116 Chouinard, S. W., Wilson, G. F., Schlimgen, A. K. & Ganetzky, B. A potassium channel beta 
subunit related to the aldo-keto reductase superfamily is encoded by the Drosophila 
hyperkinetic locus. Proc Natl Acad Sci U S A 92, 6763-6767 (1995). 
117 Long, S. B., Campbell, E. B. & Mackinnon, R. Crystal structure of a mammalian voltage-
dependent Shaker family K+ channel. Science 309, 897-903, doi:10.1126/science.1116269 
(2005). 
118 Matthies, D. et al. Single-particle cryo-EM structure of a voltage-activated potassium 
channel in lipid nanodiscs. Elife 7, doi:10.7554/eLife.37558 (2018). 
119 Liu, S. Q., Jin, H., Zacarias, A., Srivastava, S. & Bhatnagar, A. Binding of pyridine nucleotide 
coenzymes to the beta-subunit of the voltage-sensitive K+ channel. J Biol Chem 276, 
11812-11820, doi:10.1074/jbc.M008259200 (2001). 
120 Williamson, D. H., Lund, P. & Krebs, H. A. The redox state of free nicotinamide-adenine 
dinucleotide in the cytoplasm and mitochondria of rat liver. Biochem J 103, 514-527 
(1967). 
121 Pollak, N., Dolle, C. & Ziegler, M. The power to reduce: pyridine nucleotides--small 
molecules with a multitude of functions. Biochem J 402, 205-218, 
doi:10.1042/BJ20061638 (2007). 
122 Tipparaju, S. M., Barski, O. A., Srivastava, S. & Bhatnagar, A. Catalytic mechanism and 
substrate specificity of the beta-subunit of the voltage-gated potassium channel. 
Biochemistry 47, 8840-8854, doi:10.1021/bi800301b (2008). 
123 Barski, O. A., Tipparaju, S. M. & Bhatnagar, A. Kinetics of nucleotide binding to the beta-
subunit (AKR6A2) of the voltage-gated potassium (Kv) channel. Chem Biol Interact 178, 
165-170, doi:10.1016/j.cbi.2008.10.016 (2009). 
65 
124 Weng, J., Cao, Y., Moss, N. & Zhou, M. Modulation of voltage-dependent Shaker family 
potassium channels by an aldo-keto reductase. J Biol Chem 281, 15194-15200, 
doi:10.1074/jbc.M513809200 (2006). 
125 Tipparaju, S. M., Saxena, N., Liu, S. Q., Kumar, R. & Bhatnagar, A. Differential regulation 
of voltage-gated K+ channels by oxidized and reduced pyridine nucleotide coenzymes. Am 
J Physiol Cell Physiol 288, C366-376, doi:10.1152/ajpcell.00354.2004 (2005). 
126 Tipparaju, S. M. et al. Interactions between the C-terminus of Kv1.5 and Kvbeta regulate 
pyridine nucleotide-dependent changes in channel gating. Pflugers Arch 463, 799-818, 
doi:10.1007/s00424-012-1093-z (2012). 
127 Heinemann, S. H., Rettig, J., Graack, H. R. & Pongs, O. Functional characterization of Kv 
channel beta-subunits from rat brain. J Physiol 493 ( Pt 3), 625-633, 
doi:10.1113/jphysiol.1996.sp021409 (1996). 
128 Bahring, R. et al. Coupling of voltage-dependent potassium channel inactivation and 
oxidoreductase active site of Kvbeta subunits. J Biol Chem 276, 22923-22929, 
doi:10.1074/jbc.M100483200 (2001). 
129 Sokolova, O. et al. Conformational changes in the C terminus of Shaker K+ channel bound 
to the rat Kvbeta2-subunit. Proc Natl Acad Sci U S A 100, 12607-12612, 
doi:10.1073/pnas.2235650100 (2003). 
130 Xu, J. & Li, M. Kvbeta2 inhibits the Kvbeta1-mediated inactivation of K+ channels in 
transfected mammalian cells. J Biol Chem 272, 11728-11735 (1997). 
131 Nerbonne, J. M. Molecular Basis of Functional Myocardial Potassium Channel Diversity. 
Card Electrophysiol Clin 8, 257-273, doi:10.1016/j.ccep.2016.01.001 (2016). 
132 Grant, A. O. Cardiac ion channels. Circ Arrhythm Electrophysiol 2, 185-194, 
doi:10.1161/CIRCEP.108.789081 (2009). 
133 Olson, T. M. et al. Kv1.5 channelopathy due to KCNA5 loss-of-function mutation causes 
human atrial fibrillation. Hum Mol Genet 15, 2185-2191, doi:10.1093/hmg/ddl143 (2006). 
134 Christophersen, I. E. et al. Genetic variation in KCNA5: impact on the atrial-specific 
potassium current IKur in patients with lone atrial fibrillation. Eur Heart J 34, 1517-1525, 
doi:10.1093/eurheartj/ehs442 (2013). 
135 London, B. et al. Long QT and ventricular arrhythmias in transgenic mice expressing the N 
terminus and first transmembrane segment of a voltage-gated potassium channel. Proc 
Natl Acad Sci U S A 95, 2926-2931 (1998). 
136 Barry, D. M., Xu, H., Schuessler, R. B. & Nerbonne, J. M. Functional knockout of the 
transient outward current, long-QT syndrome, and cardiac remodeling in mice expressing 
a dominant-negative Kv4 alpha subunit. Circ Res 83, 560-567 (1998). 
137 Guo, W., Li, H., London, B. & Nerbonne, J. M. Functional consequences of elimination of 
i(to,f) and i(to,s): early afterdepolarizations, atrioventricular block, and ventricular 
arrhythmias in mice lacking Kv1.4 and expressing a dominant-negative Kv4 alpha subunit. 
Circ Res 87, 73-79 (2000). 
138 Aimond, F., Kwak, S. P., Rhodes, K. J. & Nerbonne, J. M. Accessory Kvbeta1 subunits 
differentially modulate the functional expression of voltage-gated K+ channels in mouse 
ventricular myocytes. Circ Res 96, 451-458, doi:10.1161/01.RES.0000156890.25876.63 
(2005). 
139 Tur, J. et al. Kvbeta1.1 (AKR6A8) senses pyridine nucleotide changes in the mouse heart 
and modulates cardiac electrical activity. Am J Physiol Heart Circ Physiol 312, H571-H583, 
doi:10.1152/ajpheart.00281.2016 (2017). 
140 Jackson, W. F. KV channels and the regulation of vascular smooth muscle tone. 
Microcirculation 25, doi:10.1111/micc.12421 (2018). 
66 
141 Cox, R. H. Molecular determinants of voltage-gated potassium currents in vascular 
smooth muscle. Cell Biochem Biophys 42, 167-195, doi:10.1385/CBB:42:2:167 (2005). 
142 Knot, H. J. & Nelson, M. T. Regulation of membrane potential and diameter by voltage-
dependent K+ channels in rabbit myogenic cerebral arteries. The American journal of 
physiology 269, H348-355. (1995). 
143 Nystoriak, M. A., Zhang, D., Jagatheesan, G. & Bhatnagar, A. Heteromeric complexes of 
aldo-keto reductase auxiliary KVbeta subunits (AKR6A) regulate sarcolemmal localization 
of KV1.5 in coronary arterial myocytes. Chem Biol Interact, doi:10.1016/j.cbi.2017.03.011 
(2017). 
144 Campomanes, C. R. et al. Kv beta subunit oxidoreductase activity and Kv1 potassium 
channel trafficking. J Biol Chem 277, 8298-8305, doi:10.1074/jbc.M110276200 (2002). 
145 Shi, G. et al. Beta subunits promote K+ channel surface expression through effects early 
in biosynthesis. Neuron 16, 843-852 (1996). 
146 Patel, A. J. & Honore, E. Molecular physiology of oxygen-sensitive potassium channels. 
Eur Respir J 18, 221-227 (2001). 
147 Thorneloe, K. S. et al. Molecular composition of 4-aminopyridine-sensitive voltage-gated 
K(+) channels of vascular smooth muscle. Circ Res 89, 1030-1037 (2001). 
148 Yuan, X. J., Tod, M. L., Rubin, L. J. & Blaustein, M. P. Contrasting effects of hypoxia on 
tension in rat pulmonary and mesenteric arteries. Am J Physiol 259, H281-289, 
doi:10.1152/ajpheart.1990.259.2.H281 (1990). 
149 Theissen, I. L. & Meissner, A. [Hypoxic pulmonary vasoconstriction]. Anaesthesist 45, 643-
652 (1996). 
150 Durmowicz, A. G. & Stenmark, K. R. Mechanisms of structural remodeling in chronic 
pulmonary hypertension. Pediatr Rev 20, e91-e102 (1999). 
151 Sweeney, M. & Yuan, J. X. Hypoxic pulmonary vasoconstriction: role of voltage-gated 
potassium channels. Respir Res 1, 40-48, doi:10.1186/rr11 (2000). 
152 Yuan, X. J. Voltage-gated K+ currents regulate resting membrane potential and [Ca2+]i in 
pulmonary arterial myocytes. Circ Res 77, 370-378 (1995). 
153 Pozeg, Z. I. et al. In vivo gene transfer of the O2-sensitive potassium channel Kv1.5 reduces 
pulmonary hypertension and restores hypoxic pulmonary vasoconstriction in chronically 
hypoxic rats. Circulation 107, 2037-2044, doi:10.1161/01.CIR.0000062688.76508.B3 
(2003). 
154 Archer, S. L. et al. Impairment of hypoxic pulmonary vasoconstriction in mice lacking the 
voltage-gated potassium channel Kv1.5. Faseb J 15, 1801-1803 (2001). 
155 Coppock, E. A. & Tamkun, M. M. Differential expression of K(V) channel alpha- and beta-
subunits in the bovine pulmonary arterial circulation. Am J Physiol Lung Cell Mol Physiol 
281, L1350-1360 (2001). 
156 Wolin, M. S., Ahmad, M. & Gupte, S. A. Oxidant and redox signaling in vascular oxygen 
sensing mechanisms: basic concepts, current controversies, and potential importance of 
cytosolic NADPH. Am J Physiol Lung Cell Mol Physiol 289, L159-173, 
doi:10.1152/ajplung.00060.2005 (2005). 
157 Norris, A. J., Foeger, N. C. & Nerbonne, J. M. Neuronal voltage-gated K+ (Kv) channels 
function in macromolecular complexes. Neurosci Lett 486, 73-77, 
doi:10.1016/j.neulet.2010.08.067 (2010). 
158 Rangaraju, S., Gearing, M., Jin, L. W. & Levey, A. Potassium channel Kv1.3 is highly 
expressed by microglia in human Alzheimer's disease. J Alzheimers Dis 44, 797-808, 
doi:10.3233/JAD-141704 (2015). 
67 
159 Pan, Y., Xu, X., Tong, X. & Wang, X. Messenger RNA and protein expression analysis of 
voltage-gated potassium channels in the brain of Abeta(25-35)-treated rats. J Neurosci 
Res 77, 94-99, doi:10.1002/jnr.20134 (2004). 
160 Villa, C. & Combi, R. Potassium Channels and Human Epileptic Phenotypes: An Updated 
Overview. Front Cell Neurosci 10, 81, doi:10.3389/fncel.2016.00081 (2016). 
161 Judge, S. I., Lee, J. M., Bever, C. T., Jr. & Hoffman, P. M. Voltage-gated potassium channels 
in multiple sclerosis: Overview and new implications for treatment of central nervous 
system inflammation and degeneration. J Rehabil Res Dev 43, 111-122 (2006). 
162 Sheng, M., Tsaur, M. L., Jan, Y. N. & Jan, L. Y. Subcellular segregation of two A-type K+ 
channel proteins in rat central neurons. Neuron 9, 271-284 (1992). 
163 Song, W. J. et al. Somatodendritic depolarization-activated potassium currents in rat 
neostriatal cholinergic interneurons are predominantly of the A type and attributable to 
coexpression of Kv4.2 and Kv4.1 subunits. J Neurosci 18, 3124-3137 (1998). 
164 Kim, J., Wei, D. S. & Hoffman, D. A. Kv4 potassium channel subunits control action 
potential repolarization and frequency-dependent broadening in rat hippocampal CA1 
pyramidal neurones. J Physiol 569, 41-57, doi:10.1113/jphysiol.2005.095042 (2005). 
165 Leicher, T., Bahring, R., Isbrandt, D. & Pongs, O. Coexpression of the KCNA3B gene product 
with Kv1.5 leads to a novel A-type potassium channel. J Biol Chem 273, 35095-35101 
(1998). 
166 Rettig, J. et al. Inactivation properties of voltage-gated K+ channels altered by presence 
of beta-subunit. Nature 369, 289-294, doi:10.1038/369289a0 (1994). 
167 Scott, V. E. et al. Primary structure of a beta subunit of alpha-dendrotoxin-sensitive K+ 
channels from bovine brain. Proc Natl Acad Sci U S A 91, 1637-1641 (1994). 
168 Coleman, S. K., Newcombe, J., Pryke, J. & Dolly, J. O. Subunit composition of Kv1 channels 
in human CNS. J Neurochem 73, 849-858 (1999). 
169 Rhodes, K. J. et al. Association and colocalization of the Kvbeta1 and Kvbeta2 beta-
subunits with Kv1 alpha-subunits in mammalian brain K+ channel complexes. J Neurosci 
17, 8246-8258 (1997). 
170 Rhodes, K. J. et al. Voltage-gated K+ channel beta subunits: expression and distribution of 
Kv beta 1 and Kv beta 2 in adult rat brain. J Neurosci 16, 4846-4860 (1996). 
171 Sandberg, R. et al. Regional and strain-specific gene expression mapping in the adult 
mouse brain. Proc Natl Acad Sci U S A 97, 11038-11043 (2000). 
172 Connor, J. X. et al. Genetic modifiers of the Kv beta2-null phenotype in mice. Genes Brain 
Behav 4, 77-88, doi:10.1111/j.1601-183X.2004.00094.x (2005). 
173 Giese, K. P. et al. Reduced K+ channel inactivation, spike broadening, and after-
hyperpolarization in Kvbeta1.1-deficient mice with impaired learning. Learn Mem 5, 257-
273 (1998). 
174 Newgard, C. B. & McGarry, J. D. Metabolic coupling factors in pancreatic beta-cell signal 
transduction. Annu Rev Biochem 64, 689-719, doi:10.1146/annurev.bi.64.070195.003353 
(1995). 
175 Yan, L. et al. Expression of voltage-gated potassium channels in human and rhesus 
pancreatic islets. Diabetes 53, 597-607 (2004). 
176 Gray, J. P., Alavian, K. N., Jonas, E. A. & Heart, E. A. NAD kinase regulates the size of the 
NADPH pool and insulin secretion in pancreatic beta-cells. Am J Physiol Endocrinol Metab 
303, E191-199, doi:10.1152/ajpendo.00465.2011 (2012). 
177 Vicente, R. et al. Association of Kv1.5 and Kv1.3 contributes to the major voltage-
dependent K+ channel in macrophages. J Biol Chem 281, 37675-37685, 
doi:10.1074/jbc.M605617200 (2006). 
68 
178 Villalonga, N. et al. Immunomodulation of voltage-dependent K+ channels in 
macrophages: molecular and biophysical consequences. J Gen Physiol 135, 135-147, 
doi:10.1085/jgp.200910334 (2010). 
179 Vicente, R. et al. Differential voltage-dependent K+ channel responses during 
proliferation and activation in macrophages. J Biol Chem 278, 46307-46320, 
doi:10.1074/jbc.M304388200 (2003). 
180 Vicente, R. et al. Pattern of Kv beta subunit expression in macrophages depends upon 
proliferation and the mode of activation. J Immunol 174, 4736-4744 (2005). 
181 Alka, K., Dolly, J. O., Ryan, B. J. & Henehan, G. T. New inhibitors of the Kvbeta2 subunit 
from mammalian Kv1 potassium channels. Int J Biochem Cell Biol 55, 35-39, 
doi:10.1016/j.biocel.2014.07.013 (2014). 
182 Pan, Y. et al. Cortisone dissociates the Shaker family K+ channels from their beta subunits. 
Nat Chem Biol 4, 708-714, doi:10.1038/nchembio.114 (2008). 
183 Virani, S. S. et al. Heart Disease and Stroke Statistics-2020 Update: A Report From the 
American Heart Association. Circulation, CIR0000000000000757, 
doi:10.1161/CIR.0000000000000757 (2020). 
184 Tsagalou, E. P. et al. Depressed coronary flow reserve is associated with decreased 
myocardial capillary density in patients with heart failure due to idiopathic dilated 
cardiomyopathy. J Am Coll Cardiol 52, 1391-1398, doi:10.1016/j.jacc.2008.05.064 (2008). 
185 Brush, J. E., Jr. et al. Angina due to coronary microvascular disease in hypertensive 
patients without left ventricular hypertrophy. N Engl J Med 319, 1302-1307, 
doi:10.1056/NEJM198811173192002 (1988). 
186 Di Carli, M. F. et al. Coronary circulatory function in patients with the metabolic syndrome. 
J Nucl Med 52, 1369-1377, doi:10.2967/jnumed.110.082883 (2011). 
187 Fukuda, D. et al. Relation between aortic stiffness and coronary flow reserve in patients 
with coronary artery disease. Heart 92, 759-762, doi:10.1136/hrt.2005.067934 (2006). 
188 Pepine, C. J. et al. Coronary microvascular reactivity to adenosine predicts adverse 
outcome in women evaluated for suspected ischemia results from the National Heart, 
Lung and Blood Institute WISE (Women's Ischemia Syndrome Evaluation) study. J Am Coll 
Cardiol 55, 2825-2832, doi:10.1016/j.jacc.2010.01.054 (2010). 
189 Merz, C. N. et al. The Women's Ischemia Syndrome Evaluation (WISE) study: protocol 
design, methodology and feasibility report. J Am Coll Cardiol 33, 1453-1461 (1999). 
190 Feigl, E. O. Coronary physiology. Physiol Rev 63, 1-205 (1983). 
191 Binak, K., Harmanci, N., Sirmaci, N., Ataman, N. & Ogan, H. Oxygen extraction rate of the 
myocardium at rest and on exercise in various conditions. Br Heart J 29, 422-427 (1967). 
192 Ohanyan, V. et al. Kv1.3 channels facilitate the connection between metabolism and 
blood flow in the heart. Microcirculation 24, doi:10.1111/micc.12334 (2017). 
193 Goodwill, A. G. et al. Critical contribution of KV1 channels to the regulation of coronary 
blood flow. Basic Res Cardiol 111, 56, doi:10.1007/s00395-016-0575-0 (2016). 
194 Nishijima, Y. et al. Shaker-related voltage-gated K(+) channel expression and vasomotor 
function in human coronary resistance arteries. Microcirculation 25, 
doi:10.1111/micc.12431 (2018). 
195 West, J. et al. Pulmonary hypertension in transgenic mice expressing a dominant-negative 
BMPRII gene in smooth muscle. Circ Res 94, 1109-1114, 
doi:10.1161/01.RES.0000126047.82846.20 (2004). 
196 Nystoriak, M. A. et al. Fundamental increase in pressure-dependent constriction of brain 
parenchymal arterioles from subarachnoid hemorrhage model rats due to membrane 
69 
depolarization. Am J Physiol Heart Circ Physiol 300, H803-812, 
doi:10.1152/ajpheart.00760.2010 (2011). 
197 Nystoriak, M. A. et al. Ser1928 phosphorylation by PKA stimulates the L-type Ca2+ channel 
CaV1.2 and vasoconstriction during acute hyperglycemia and diabetes. Sci Signal 10, 
doi:10.1126/scisignal.aaf9647 (2017). 
198 Nelson, M. T., Patlak, J. B., Worley, J. F. & Standen, N. B. Calcium channels, potassium 
channels, and voltage dependence of arterial smooth muscle tone. Am J Physiol 259, C3-
18, doi:10.1152/ajpcell.1990.259.1.C3 (1990). 
199 Sato, A. et al. Mechanism of vasodilation to adenosine in coronary arterioles from 
patients with heart disease. Am J Physiol Heart Circ Physiol 288, H1633-1640, 
doi:10.1152/ajpheart.00575.2004 (2005). 
200 Kilfoil, P. J. et al. Metabolic regulation of Kv channels and cardiac repolarization by 
Kvbeta2 subunits. Journal of molecular and cellular cardiology 137, 93-106, 
doi:10.1016/j.yjmcc.2019.09.013 (2019). 
201 Blair, M. L. Sex-based differences in physiology: what should we teach in the medical 
curriculum? Adv Physiol Educ 31, 23-25, doi:10.1152/advan.00118.2006 (2007). 
202 Miller, V. M. et al. Strategies and methods to study sex differences in cardiovascular 






































Sean Michael Raph 
ADDRESS: Diabetes and Obesity Center 
School of Medicine 
Department of Environmental Medicine 
Delia Baxter II Building 
580 S Preston St. 
University of Louisville 
Louisville, KY 40202 
 
Department of Pharmacology and Toxicology 
School of Medicine 
Clinical and Translational Research Building 
505 S. Hancock St. 
University of Louisville 
Louisville, KY 40202 
 







University of Maine at Farmington 
2008-2012 
 
Undergraduate Research Project 
Organic Chemistry 
Dr. Mariella Passarelli 




Wise Laboratory of Environmental and Genetic 
Toxicology 
71 
Thesis: “Effects of Cobalt on DNA Double Strand 
Break Repair-Deficient Cells” 
Dr. John P. Wise Sr. 
University of Southern Maine 
2012-2015 
 Graduate Teaching Assistant, Biology 
Introduction to Biology and Anatomy and Physiology 
University of Southern Maine 
Drs. David Champlin and Doug Currie 
2012-2014 
 
Adjunct Faculty, Biology 
Anatomy and Physiology 
University of Southern Maine 
Drs. David Champlin and Doug Currie 
2014-2014 
 
Scientist 1 (temp.) 
Product Development 
Corning Inc.  
Greg Martin 
2015-2016 (15 mo.) 
 
Visiting Scholar/Research Tech 1 
Pharmacology and Toxicology 
University of Louisville 
Dr. John P. Wise Sr. 
2016-2017 
 
Graduate Research Assistant 
Pharmacology and Toxicology 
University of Louisville 
Dr. John P. Wise Sr. 
2017-2018 
 
Graduate Research Assistant 
Pharmacology and Toxicology, Environmental 
Medicine: Diabetes and Obesity Center 
University of Louisville 






American Heart Association, 2019 – current 
American Society for Pharmacology and Experimental 




2nd place masters’ candidate poster presentation; 
Research!Louisville, University of Louisville, 2019 
 
Best Poster Award – Graduate Student, 
Environmental research and cardiovascular disease; 
Southeast Regional IDeA Conference, Galt House, 
Louisville, KY November 6-8th 2019 
 
PUBLICATIONS:  
Ohanyan V, Raph SM, Dwenger MM, Hu X, Pucci T, 
Mack GD, Moore Iv JB, Chilian WM, Bhatnagar A, 
Nystoriak MA. Myocardial Blood Flow Control by 
Oxygen Sensing Vascular Kvβ Proteins. Circ Res. 
2021 Jan 27. doi: 
10.1161/CIRCRESAHA.120.317715. Epub ahead of 
print. PMID: 33499656. 
 
Raph, S.M., Bhatnagar, A., Nystoriak, M.A. (2020). 
The enzymatic function of Kvβ2 contributes to 
resistance artery vasodilation. The FASEB journal 
vol.34, S1. (Abstract). 
 
Raph, S.M., Bhatnagar, A., and Nystoriak, M.A. 
(2019). Biochemical and physiological properties of K+ 
channel associated AKR6A (Kvβ) proteins. Chemico-







Southeast Regional IDeA Conference, Galt House, 
Louisville, KY November 6-8th 2019; “Redox changes 
in the NADH:NAD+ ratio induces vasodilation via the 
KV1 redox sensing subunit KVβ2” 
    
 
